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ABSTRACT
We estimate the magnitude of spillovers generated by 112 academic "superstars" who died pre- maturely
and unexpectedly, thus providing an exogenous source of variation in the structure of their collaborators'
coauthorship networks. Following the death of a superstar, we find that collaborators experience, on
average, a lasting 5 to 8% decline in their quality-adjusted publication rates. By exploring interactions
of the treatment effect with a variety of star, coauthor and star/coauthor dyad characteristics, we seek
to adjudicate between plausible mechanisms that might explain this finding. Taken together, our results
suggest that spillovers are circumscribed in idea space, but less so in physical or social space. In particular,
superstar extinction reveals the boundaries of the scientific field to which the star contributes — the
"invisible college."
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1 Introduction
Although the production of ideas occupies a central role in modern theories of economic
growth (Romer 1990), the creative process remains a black box for economists (Weitzman
1998 and Jones 2009 are notable exceptions). How do innovators actually generate new
ideas? Increasingly, discoveries result from the voluntary sharing of knowledge through
collaboration, rather than individual eorts (Wuchty et al. 2007). The growth of scientic
collaboration has important implications for the optimal allocation of public R&D funds,
the apportionment of credit amongst scientists, the formation of scientic reputations, and
ultimately the design of research incentives that foster innovation and continued economic
growth. Yet, we know surprisingly little about the role of collaboration among peers as a
mechanism to spur the creation of new technological or scientic knowledge.
This paucity of evidence is largely due to the empirical challenges inherent to this line
of inquiry. Individual-level data on the contributors to a particular innovation are generally
unavailable. Furthermore, the formation of collaborative teams is the outcome of a purposeful
matching process (Mairesse and Turner 2005; Fafchamps et al. 2008), making it dicult to
uncover causal eects. The design of our study tackles both of these challenges. To relax the
data constraint, we focus on the academic life sciences, where a rich tradition of coauthorship
provides an extensive paper trail of collaboration histories and research output. To overcome
the endogeneity of the collaboration decision, we make use of the quasi-experimental variation
in the structure of coauthorship networks induced by the premature and sudden death of
active \superstar" scientists.1
1Other economists have used the death of prominent individuals as a source of exogenous variation in
leadership, whether in the context of business rms (Bennedsen et al. 2008), or even entire countries (Jones
and Olken 2005). To our knowledge, however, we are the rst to use this strategy to estimate the impact
1Specically, we analyze changes in the research output of collaborators for 112 eminent life
scientists who die suddenly and unexpectedly. We assess eminence based on the combination
of seven criteria, and our procedure is exible enough to capture established scientists with
extraordinary career achievement, as well as promising young and mid-career scientists.
Using the Association of American Medical Colleges (AAMC) Faculty Roster as a data
source | a comprehensive, longitudinal, matched employee-employer database pertaining to
230,000 faculty members in all U.S. medical schools between 1975 and 2006 | we construct
a panel dataset of 5,267 collaborator-star pairs, and we examine how coauthors' scientic
output (as measured by publications, citations, and National Institutes of Health (NIH)
grants) changes when the superstar passes away.2
The study's focus on the scientic elite can be justied both on substantive and pragmatic
grounds. The distribution of publications, funding, and citations at the individual level is
extremely skewed (Lotka 1926; de Solla Price 1963) and only a tiny minority of scientists
contribute through their published research to the advancement of science (Cole and Cole
1972). Stars also leave behind a corpus of work and colleagues with a stake in the preservation
of their legacy, making it possible to trace back their careers, from humble beginnings to
wide recognition and acclaim.
Our results reveal a lasting 5 to 8% decrease in the quality-adjusted publication output
of coauthors in response to the sudden and unexpected loss of a superstar. Though close
and recent collaborators see their scientic output fall even more, these dierential eects
are small in magnitude and statistically insignicant. Therefore, the process of replacing
missing skills within ongoing collaborative teams cannot, on its own, explain our core result.
The importance of learning through on-the-job social interactions can be traced back to
the talmudic era (as evidenced by the epigraph to this paper), as well as canonical writings
of scientic collaboration. Oettl (2008) builds on our approach by incorporating helpfulness as implied
by acknowledgements to generate a list of eminent immunologists. Aizenman and Kletzer (2008) study
the citation \afterlife" of 16 economists who die prematurely, shedding light on the survival of scientic
reputation.
2To be clear, our focus is on faculty peers rather than trainees, and thus our results should be viewed as
capturing inter-laboratory spillovers rather than mentorship eects. For evidence on the latter, see Azoulay
et al. (2009).
2by Alfred Marshall (1890) and Robert Lucas (1988).3 Should the eects of exposure to
superstar talent be interpreted as laying bare the presence of knowledge spillovers? Since we
identify 47 coauthors per superstar on average, we exploit rich variation in the characteristics
of collaborative relationships to assess the relative importance of several mechanisms which
could plausibly account for our main nding.
A jaundiced view of the academic reward system provides the backdrop for a broad
class of stories. Their common thread is that collaborating with superstars deepens social
connections that might make researchers more productive in ways that have little to do with
scientic knowledge, for example by connecting coauthors to funding resources, editorial
goodwill, or potential coauthors. Yet, we nd no dierential impact on coauthors of stars
well-connected to the NIH funding apparatus, on coauthors of stars more central in the
collaboration network, or on former trainees. These ndings do not jibe with explanations
stressing the gatekeeping role of eminent scientists.
Rather, the eects of superstar extinction appear to be driven by the loss of an irre-
placeable source of ideas. We nd that coauthors proximate to the star in intellectual space
experience a sharper decline in output, relative to coauthors who work on less related topics.
Furthermore, the collaborators of stars whose work was heavily cited at the time of their
death also undergo steeper decreases, relative to collaborators of superstars of less renown.
Together, these results paint a picture of an invisible college of coauthors bound together
by interests in a fairly specic scientic area, which suers a permanent and reverberating
intellectual loss when it loses its star.
The rest of the paper proceeds as follows. In the next section, we describe the construction
of the sample of matched superstars and collaborators, as well as our empirical strategy.
Section 3 provides descriptive statistics at the coauthor and dyad level. We report the
results in section 4. Section 5 concludes.
3A burgeoning empirical literature examines the inuence of peer eects on shirking behavior in the
workplace (Costa and Khan 2003; Bandiera et al. 2005; Mas and Moretti 2009). Since \exposure" does not
involve the transmission of knowledge, these spillovers are conceptually distinct from those that concern us
here.
32 Setting, Data, and Matched Sample Construction
The setting for our empirical work is the academic life sciences. This sector is an important
one to study for several reasons. First, there are large public subsidies for biomedical research
in the United States. With an annual budget of $29.5 billion in 2008, support for the NIH
dwarfs that of other national funding agencies in developed countries (Cech 2005). Deepening
our understanding of knowledge production in this sector will allow us to better assess the
return to these public investments.
Second, technological change has been enormously important in the growth of the health
care economy, which accounts for roughly 15% of US GDP. Much biomedical innovation is
science-based (Henderson et al. 1999), and interactions between academic researchers and
their counterparts in industry appear to be an important determinant of research produc-
tivity in the pharmaceutical industry (Cockburn and Henderson 1998; Zucker et al. 1998).
Third, academic scientists are generally paid through soft money contracts. Salaries
depend on the amount of grant revenue raised by faculty, thus providing researchers with
high-powered incentives to remain productive even after they secure a tenured position.
Lastly, introspective accounts by practicing scientists indicate that collaboration plays a
large role in both the creation and diusion of new ideas (Reese 2004). Knowledge and tech-
niques often remain partially tacit until long after their initial discovery, and are transmitted
within the connes of tightly-knit research teams (Zucker and Darby 2008).
2.1 Superstar Sample
Our basic approach is to rely on the death of \superstar" scientists to estimate the magnitude
of knowledge spillovers onto colleagues. From a practical standpoint, it is more feasible to
trace back the careers of eminent scientists than to perform a similar exercise for less eminent
ones. We began by delineating a set of 10,349 \elite" life scientists (roughly 5% of the entire
relevant labor market) who are so classied if they satisfy at least one of the following criteria
4for cumulative scientic achievement: (1) highly funded scientists; (2) highly cited scientists;
(3) top patenters; and (4) members of the National Academy of Sciences.
These four criteria will tend to select seasoned scientists, since they correspond to ex-
traordinary achievement over an entire scientic career. We combine these measures with
three others that capture individuals who show great promise at the early and middle stages
of their scientic careers, whether or not these episodes of productivity endure for long pe-
riods of time: (5) NIH MERIT awardees; (6) Howard Hughes Medical Investigators; and
(7) early career prize winners. Appendix I provides additional details regarding these seven
metrics of \superstardom."
We trace back these scientists' careers from the time they obtain their rst position as
independent investigators (typically after a postdoctoral fellowship) until 2006. We do so
through a combination of curriculum vits, NIH biosketches, Who's Who proles, acco-
lades/obituaries in medical journals, National Academy of Sciences biographical memoirs,
and Google searches. For each one of these individuals, we record employment history,
degree held, date of degree, gender, and up to three departmental aliations. We also cross-
reference the list with alternative measures of scientic eminence. For example, the elite
subsample contains every U.S.-based Nobel Prize winner in Medicine and Physiology since
1975, and a plurality of the Nobel Prize winners in Chemistry over the same time period.
Though we apply the convenient moniker of \superstar" to the entire group, it should be
clear that there is substantial heterogeneity in intellectual stature within the elite sample.
This variation provides a unique opportunity to examine whether the eects we estimate
correspond to vertical eects (spillovers from the most talented agents onto those who are
less distinguished) rather than peer eects (spillovers between agents of roughly comparable
stature).
The scientists who are the focus of this paper constitute a subset of this larger pool of
10,349. We impose several additional criteria to derive the nal list. First, the scientist's
death must intervene between 1979 and 2003. This will enable us to observe at least 4 years'
(resp. 3 years') worth of scientic output for every colleague before (resp. after) the death
5of their superstar collaborator. Second, they must be 67 years of age or less at the time of
their passing (we will explore the sensitivity of our results to this age cuto later). Third, we
require evidence, in the form of published articles and/or NIH grants, that these scientists
have not entered a pre-retirement phase of their career prior to the time of death. This
constraint is somewhat subjective, but we validate in the on-line appendix our contention
that the nal set is limited to scientists who are \research-active" at the time of their death.
These sequential screens delineate a set of 248 scientists. Finally, we limit our attention to
the subset of stars who died suddenly and unexpectedly. This is less dicult that it might
seem, since the vast majority of obituaries mention the cause of death explicitly.4 After
eliminating 136 scientists whose death could have been anticipated by their colleagues, we
are left with 112 extinct superstars (their names, cause of death, and institutional aliations
are listed in Table W1 in the on-line appendix).
Table I provides descriptive statistics for the superstar sample. The average star received
his degree in 1963, died at 57 years old and worked with 47 coauthors during his lifetime.
On the output side, the stars each received an average of roughly 11 million dollars in NIH
grants (excluding center grants), and published 139 papers that garnered 8,190 citations as
of early 2008.
2.2 The Universe of Potential Colleagues
Information about the superstars' colleagues stems from the Faculty Roster of the Association
of American Medical Colleges, to which we secured licensed access for the years 1975 through
2006. The roster is an annual census of all U.S. medical school faculty in which each faculty
is linked across yearly cross-sections by a unique identier.5 When all cross-sections are
pooled, we obtain a matched employee/employer panel dataset. For each of the 230,000
faculty members that appear in the roster, we know the full name, the type of degrees
4We exclude from the sample one scientist who took his own life, and a further two for whom suicide
could not be ruled out. In 10 other instances, the cause of death could not be ascertained from the obituaries
and we contacted former collaborators individually to clarify the circumstances of the superstar's passing.
5AAMC does not collect data from each medical school with a xed due date. Instead, it collects data
on a rolling basis, with each medical school submitting on a time frame that best meets its reporting needs.
Nearly all medical schools report once a year, while many medical schools update once a semester.
6received and the years they were awarded, gender, up to two departments, and medical
school aliation. An important implication of our reliance on the AAMC Faculty Roster is
that the interactions we can observe in the data take place between faculty members, rather
than between faculty members and trainees (graduate students or post-doctoral fellows).6
Because the roster only lists medical school faculty, however, it is not a complete census of
the academic life sciences. For instance, it does not list information for faculty at institutions
such as MIT, University of California at Berkeley, Rockefeller University, the Salk Institute,
or the Bethesda campus of the NIH; and it also ignores faculty members in Arts and Sciences
departments | such as biology and chemistry | if they do not hold joint appointments at
a local medical school.7
Our interest lies in assessing the benets of exposure to superstar talent that accrue
through collaboration. Therefore, we focus on the one-degree, egocentric coauthorship net-
work for the sample of 112 extinct superstars. To identify coauthors, we have developed
a software program, the Stars/Colleague Generator, or S/CGen.8 The source of the pub-
lication data is PubMED, an online resource from the National Library of Medicine that
provides fast, free, and reliable access to the biomedical research literature. In a rst step,
S/CGen downloads from the internet the entire set of English-language articles for a su-
perstar, provided they are not letters to the editor, comments, or other \atypical" articles.
From this set of publications, S/CGen strips out the list of coauthors, eliminates duplicate
names, matches each coauthor with the Faculty Roster, and stores the identier of every
coauthor for whom a match is found. In a nal step, the software queries PubMED for each
6To the extent that former trainees go on to secure faculty positions, they will be captured by our
procedure even if the date of coauthorship predates the start of their independent career.
7This limitation is less important than might appear at rst glance. First, we have no reason to think
that colleagues located in these institutions dier in substantive ways from those based in medical schools.
Second, all our analyses focus on changes in research productivity over time for a given scientist. Therefore,
the limited coverage is an issue solely for the small number of faculty who transition in and out of medical
schools from (or to) other types of research employment. For these faculty, we were successful in lling career
gaps by combining the AAMC Faculty Roster with the NIH data.
8The software can be used by other researchers under an open-source (GNU) license. It can be down-
loaded, and detailed specications accessed, from the web site http://stellman-greene.com/SCGen/. Note
that the S/CGen takes the AAMC Faculty Roster as an input; we are not authorized to share this data
with third-parties. However, it can be licensed from AAMC, provided a local IRB gives its approval and a
condentiality agreement protects the anonymity of individual faculty members.
7validated coauthor, and generates publication counts as well as coauthorship variables for
each superstar/colleague dyad, in each year. In the on-line appendix, we provide details on
the matching procedure, how we guard against the inclusion of spurious coauthors, and our
approach to addressing measurement error when tallying the publication output of coauthors
with common names.
2.3 Identication Strategy
A natural starting point to identify the eect of superstar death is to examine changes
in collaborator research output after the superstar passes away, relative to when s/he was
still alive, using a simple collaborator xed eects specication. Since the extinction eect
is mechanically correlated with the passage of time, as well as with coauthor's age, our
specications must include life cycle and period eects, as is the norm in studies of scientic
productivity (Levin and Stephan 1991). In this framework, the control group that pins down
the counterfactual age and calendar time eects for the coauthors that currently experience
the death of a superstar consists of coauthors whose associated superstar died in earlier
periods, or will die in future periods. Despite its long pedigree in applied economics (e.g.,
Grogger 1995; Reber 2006), this approach may be problematic in our setting.
First, coauthors observed in periods after the death of their associated superstar are
not appropriate controls if the event negatively aected the trend in their output; if this
is the case, xed eects will underestimate the true eect of superstar extinction. Second,
collaborations might be subject to idiosyncratic life cycle patterns, with their productive
potential rst increasing over time, eventually peaking, and thereafter slowly declining; if
this is the case, xed eects will overestimate the true eect of superstar extinction, at least
if we rely on collaborators treated in earlier or later periods as as an \implicit" control group.
To mitigate these threats to identication, our preferred empirical strategy relies on the
selection of a matched control for each scientist who experiences the death of a superstar
collaborator. These control scientists are culled from the universe of coauthors for the
10,000 superstars who do not die (see Section 2.1). Combining the treated and control
8samples enables us to estimate the eect of superstar extinction in a dierence in dierences
framework. Using a \coarsened exact matching" procedure detailed in Appendix II, the
control coauthors are chosen so that (1) treated scientists exhibit no dierential output
trends relative to controls up to the time of superstar death; (2) the distributions of career
age at the time of death are similar for treated and controls; (3) the time paths of output
for treated and control coauthors are similar up to the time of death; and (4) the dynamics
and main features of collaboration (number of coauthorships at the time of death, time
elapsed since rst and last coauthorship; status of the superstar collaborator as summarized
by cumulative citations in the year of death) are balanced between treated and controls.
However, adding this control group to the basic regression does not, by itself, yield a spec-
ication where the control group consists exclusively of matched controls. Figure A1 displays
the trends in average and median number of quality-adjusted publications, for treated and
control collaborators respectively, without any adjustment for age or calendar time eects.
This raw comparison is not without its problems, since it involves centering the raw data
around the time of death, thus ignoring the lack of congruence between experimental and
calendar time. Yet, it is completely non-parametric, and provides early evidence that the
loss of a superstar coauthor leads to a decrease in collaborators' publication output. Fur-
thermore, the magnitude of the estimates presented below are very similar whether or not
control scientists are added to the estimation sample.
Another potential concern with the addition of this \explicit" control group is that control
coauthors could be aected by the treatment of interest. No scientist is an island. The set
of coauthors for our 10,349 elite scientists comprises 65% of the labor market, and the
remaining 35% corresponds in large part to clinicians who hold faculty appointments but
do not publish regularly. Furthermore, the death of a prominent scientist could aect the
productivity of non-coauthors if meaningful interactions take place in \idea space," as we
propose. Thus, in robustness checks, we check whether eliminating from the estimation
sample treated and control collaborators separated by small path lengths in the coauthorship
network matters for the substance, or even the magnitudes, of our main results.
93 Descriptive Statistics
When applied to our sample of 112 extinct superstars, S/CGen identies 5,267 distinct
coauthors with unique PubMED names.9 Our matching procedure can identify a control
scientist for 5,064 (96%) of the treated collaborators. The descriptive statistics in Table II
pertain to the set of 2  5;064 = 10;128 matched treated and control scientists. The
covariates of interest are measured in the year of the (possibly counterfactual) year of death
for the superstar. We distinguish between variables that are inherently dyadic (e.g., co-
location at time of death) from variables that characterize the coauthor at a particular point
of time (e.g., NIH R01 funding at the time of death).
Dyadic variables. Of immediate interest is the distribution of coauthorship intensity at
the dyad level. While the average number of coauthorships is slightly less than three, the
distribution is extremely skewed (Figure I). We dene \casual" dyads as those that have
two or fewer coauthorships with the star, \regular" dyads as those with three to nine coau-
thorships, and \close" dyads as those with ten or more coauthorships. Using these cutos,
\regular" dyads correspond to those between the 75th and the 95th percentile of coauthorship
intensity, while \close" dyads correspond to those above the 95th percentile.
We focus next on collaboration age and recency. On average, collaborations begin 11 years
before the star's death, and time since last coauthorship is slightly more than 9 years. In
other words, most of the collaborations in the sample do not involve active research projects
at the time of death. Recent collaborations (those that involve at least one coauthorship
in the three years preceding the passing of the superstar) map into the top quartile of
collaboration recency at the dyad level.
The research collaborations studied here occur between faculty members, who often run
their own labs (a conjecture reinforced by the large proportion of coauthors with independent
NIH funding). Yet, it is interesting to distinguish collaborators who trained under a superstar
9Whenever a scientist collaborates with more than one extinct superstar (this is relevant for 10% of the
sample), we take into account only the rst death event. We have veried that limiting the estimation sample
to collaborators with one and only one tie to a superstar who dies does not change the substance, or even
the magnitudes, of our core result.
10(either in graduate school or during a postdoctoral fellowship) from those collaborations
initiated at a time in which both nodes in the dyad already had a faculty appointment. While
there is no roster of mentor/mentee pairs, coauthorship norms in the life sciences provide an
opportunity to identify former trainees. Specically, we ag rst-authored articles published
within a few years of receipt of the coauthor's degree in which the superstar appears in last
position on the authorship roster.10 Using this method, we nd that roughly 8% of treated
collaborators were former trainees of the associated superstar.
We now examine the spatial distribution of collaborations. Slightly more than 12% of
collaborations correspond to scientists who were co-located at the time of superstar extinc-
tion; though this is not the focus of the paper, the proportion of local collaborations has
declined over time, as many previous authors have documented (e.g., Rosenblat and M obius
2004). We also provide a measure of collaborators' proximity in \ideas space." Every pub-
lication indexed by PubMED is tagged by a large number of descriptors, selected from a
dictionary of approximately 25,000 MeSH (Medical Subject Headings) terms. Our measure
of intellectual proximity between members of a dyad is simply the number of unique MeSH
terms which overlap in their non-coauthored publications, normalized by the total number
of MeSH terms used by the superstar's coauthor. The time window for the calculation is
the ve years that precede the passing of the superstar. The distribution of this variable is
displayed in Figure II.11
Finally, we create a measure of social proximity that relies not on the quantity of coau-
thored output, but on the degree of social interaction it implies. We focus on the pairs
involving coauthors who, whenever they collaborate, nd themselves in the middle of the
authorship list. Given the norms that govern the allocation of credit in the life sciences,
these coauthors are likely to share the least amount of social contact. 7.5% of the dyads in
10The purported training period runs from 3 years before graduation to 4 years after graduation for PhDs
and MD/PhDs; and from the year of graduation to 6 years after graduation for MDs. Recall that we do not
observe the population of former trainees, but only those trainees that subsequently went on to get full-time
faculty positions in the United States. One concern is selection bias for the set of former trainees associated
with superstars who died when they had just completed training. To guard against this potential source of
bias, we eliminated all former trainees from the sample with career age less than 5 at the time of death.
11Further details on its construction are provided in the on-line appendix, Section II.
11the sample correspond to this situation of \accidental coauthorship" | the most tenuous
form of collaboration.
Coauthor variables. We briey mention demographic characteristics that do not play a
role in the econometric results but are nonetheless informative. The sample is 20% female
(only 10% of the superstars are women); approximately half of all coauthors are MDs, 40%
are PhDs, and the remainder are MD/PhDs; and a third are aliated with basic science
departments (as opposed to clinical or public health departments). The coauthors are about
8 years younger than the superstars on average (1971 vs. 1963 for the year of highest degree).
Coauthors lag behind superstars in terms of publication output at the time of death,
but the dierence is not dramatic (88 vs. 140 articles, on average). Assortative matching is
present in the market for collaborators, as reected by the fact that 2,852 (28.16%) of our
10,128 coauthors belong to the elite sample of 10,349 scientists. 55% of collaborators had
served as PI on at least one NIH R01 grant when the superstar passes away, while about
8% of the treated collaborators (and 9% of the controls) belong to a more exclusive elite:
Howard Hughes Medical Investigators, members of the NAS, or MERIT awardees.
The estimation sample pools observations between 1975 and 2006 for the dyads described
above. The result is an unbalanced panel dataset with 153,508 collaboratoryear observa-
tions (treated collaborators only) or 294,943 collaboratoryear observations (treated and
control collaborators).
4 Results
The exposition of the econometric results proceeds in three stages. After a brief review
of methodological issues, we provide results that pertain to the main eect of superstar
exposure on publication rates. Second, we examine whether this eect merely reects the
adverse impact of losing important skills within ongoing collaborative teams. Third, we
attempt to explicate the mechanism, or set of mechanisms, responsible for the results. We
12do so by exploring heterogeneity in the treatment through the interaction of the post-death
indicator variable below with various attributes of the superstar, colleague, and dyad.
4.1 Econometric Considerations
Our estimating equation relates colleague j's output in year t to characteristics of j, super-
star i, and dyad ij:
E [yjtjXijt] = exp[0 + 1AFTER DEATHit + f(AGEjt) + t + ij] (1)
where y is a measure of research output, AFTER DEATH denotes an indicator variable
that switches to one the year after the superstar dies, f(AGEjt) corresponds to a exible
function of the colleague's career age, the t's stand for a full set of calendar year indicator
variables, and the ij's correspond to dyad xed eects, consistent with our approach to
analyze changes in j's output following the passing of superstar i.
The dyad xed eects control for many individual characteristics that could inuence
research output, such as gender or degree. Academic incentives depend on the career stage;
given the shallow slope of post-tenure salary increases, Levin and Stephan (1991) suggest
that levels of investment in research should vary over the career life cycle. To exibly account
for life cycle eects, we include seventeen indicator variables corresponding to dierent career
age brackets, where career age measures the number of years since a scientist earned his/her
highest degree (MD or PhD).12 In specications that include an interaction between the
treatment eect and some covariates, the models also include a set of interactions between
the life cycle eects and these covariates.
Estimation. The dependent variables of interest, including weighted or unweighted publi-
cation counts and NIH grants awarded, are skewed and non-negative. For example, 24.80%
of the collaborator/year observations in the data correspond to years of no publication out-
put; the gure climbs to 87.40% if one focuses on the count of successful grant applications.
12The omitted category corresponds to faculty members in the very early years of their careers (before age -
3). It is not possible to separately identify calendar year eects from age eects in the \within" dimension
of a panel in a completely exible fashion, because one cannot observe two individuals at the same point in
time that have the same (career) age but earned their degrees in dierent years (Hall et al. 2007).
13Following a long-standing tradition in the study of scientic and technical change, we present
conditional quasi-maximum likelihood estimates based on the xed-eect Poisson model de-
veloped by Hausman et al. (1984). Because the Poisson model is in the linear exponential
family, the coecient estimates remain consistent as long as the mean of the dependent
variable is correctly specied (Gouri eroux et al. 1984).13
Inference. QML (i.e., \robust") standard errors are consistent even if the underlying data
generating process is not Poisson. In fact the Hausman et al. estimator can be used for any
non-negative dependent variables, whether integer or continuous (Santos Silva and Tenreyro
2006), as long as the variance/covariance matrix is computed using the outer product of the
gradient vector (and therefore does not rely on the Poisson variance assumption). Further,
QML standard errors are robust to arbitrary patterns of serial correlation (Wooldridge 1997),
and hence immune to the issues highlighted by Bertrand et al. (2004) concerning inference
in DD estimation. We cluster the standard errors around superstar scientists in the results
presented below.
Dependent Variables. Our primary outcome variable is a coauthor's number of publica-
tions. Since SC/Gen matches the entire authorship roster for each article, we can separate
those publications coauthored with the superstar from those produced independently of
him/her. We perform a quality adjustment by weighting each publication by its Journal
Impact Factor (JIF) | a measure of the frequency with which the \average article" in a
journal has been cited in a particular year. One obvious shortcoming of this adjustment
is that it does not account for dierences in impact within a given journal. In the on-line
appendix (section V), we present additional results based on article-level citation outcomes.
4.2 Main eect of superstar extinction
Table III presents our core results. Column 1a examines the determinants of the 5,267 treated
coauthors' JIF-weighted publication output. We nd a sizable and signicant 8.8% decrease
13In the on-line appendix (section IV), we show that OLS yields very similar results to QML Poisson
estimation for our main ndings.
14in the yearly number of quality-adjusted publications coauthors produce after the star dies.
Column 2b adds the set of control coauthors to the estimation sample. This reduces only
slightly our estimate of the treatment eect, to a statistically signicant 8.2% decline.
Columns 1b and 2b provide the results for an identical set of specications, except that we
modify the dependent variable to exclude publications coauthored with the superstar when
computing the JIF-weighted publication counts. The contrast between the results in Panels A
and B elucidates scientists' ability to substitute towards new collaborative relationships
upon the death of their superstar coauthor. The eects are now smaller, but they remain
statistically signicant.
We also explore the dynamics of the eects uncovered in Table III. We do so by estimating
a specication in which the treatment eect is interacted with a set of indicator variables
corresponding to a particular year relative to the superstar's death, and then graphing the
eects and the 95% condence interval around them (Figures IIIA and IIIB, corresponding
to Table III, columns 1b and 2b). Following the superstar's death, the treatment eect
increases monotonically in absolute value, becoming statistically signicant three to four
years after death. Two aspects of this result are worthy of note. First, we nd no evidence
of recovery | the eect of superstar extinction appears permanent. Though we will explore
mechanisms in more detail below, this seems inconsistent with a bereavement-induced loss
in productivity. Second, the delayed onset of the eect makes sense because it plausibly
takes some time to exhaust the productive potential of the star's last scientic insights. In
addition, the typical NIH grant cycle is three to ve years, and the impact of a superstar's
absence may not really be felt until it becomes time to apply for a new grant.
In all specications, the results with and without controls are quite similar. In the
remainder of the paper, the estimations sample always include the \explicit" control group,
though the results without it are qualitatively similar.
154.3 Imperfect Skill Substitution
Collaborative research teams emerge to pool the expertise of scientists, who, in their individ-
ual capacity, face the \burden of knowledge" problem identied by Jones (2009). Upon the
death of a key collaborator, other team members might struggle to suitably replace the pieces
of knowledge that were embodied in the star. Viewed in this light, the eects uncovered in
Table III could be considered unsurprising | a mechanical reection of the skill substitution
process. The fact that publications with coauthors other than the superstar are adversely
aected, and the permanence of the treatment eect already suggest other forces are at
play. The imperfect skill substitution (ISS) story carries additional testable implications.
First, one would expect coauthors with closer relationships with the star to suer steeper
decreases in output; the same would be expected for recent or new collaborations, which are
more likely to involve ongoing research eorts at the time of death. Table IV examines these
implications empirically.
We nd that regular, and to a lesser extent, close collaborators are indeed more neg-
atively aected than casual collaborators, but these dierential losses are relatively small
in magnitude and statistically insignicant (column 1a). The same holds true for recent
collaborations (at least one joint publication in the three years preceding the star's death,
column 2a) and for \young" collaborations (those for which the rst coauthored publica-
tion appeared in the ve years preceding the star's death, unreported results available from
the authors). Columns 1b and 2b provide results for an identical set of specications, but
excluding publications coauthored with the superstar. The contrast between the results in
columns 1a and 1b (resp. 2a and 2b) elucidates scientists' ability to substitute towards new
collaborative relationships upon the death of their superstar coauthor. The estimates imply
that close and, to a lesser extent, recent coauthors do manage to nd replacement collab-
orators (or to intensify already existing collaborations). Close collaborators experience an
imprecisely estimated 6.18% average increase in their quality-adjusted publications written
independently of the star, but this is only a partial oset for the overall loss documented
in column 1a. We nd that casual collaborators and collaborators without a recent coau-
16thorship see their independent output decline respectively by 5.54% (column 1b) and 8.25%
(column 2b). Very similar results are obtained when combining all these covariates into one
specication (columns 3a and 3b).
While the dierential impacts on the closest and most recent collaborators are not statis-
tically signicant, they do appear to move in the direction that supports the skill substitution
hypothesis. However, the inability of scientists to fully compensate for the loss of expected
future collaborations through alternative relationships, as well as the permanence of the
extinction eect, demonstrate that something more than the star's skills disappears upon
their death. Taken as a whole, these results suggest that the treatment eect from Table III
cannot be fully explained by imperfect skill substitution within ongoing teams.
4.4 Disentangling Mechanisms
We exploit the ne-grained level of detail in the data to sort between mechanisms which
might underlie the extinction eect. Are collaborative ties with superstars conduits for
tangible resources, or for knowledge and ideas? These two broad classes of explanations
are not mutually exclusive, but ascertaining their relative importance matters because their
welfare implications dier sharply. If superstars merely act as gatekeepers, then their deaths
will lead to a reallocation of resources away from former collaborators, but may have little
impact on social welfare. Conversely, if spillovers of knowledge were enabled by collaboration,
their passing might result in signicant welfare losses.
Superstars as Gatekeepers. Superstars may matter for their coauthors because they
connect them to important resources either within their institution or in the scientic world
at large. These resources might include funding, administrative clout, editorial goodwill,
or other potential collaborators. We attempt to evaluate the validity of three particular
implications of this story in Table V.
First, we examine whether the superstar's ties to the NIH funding apparatus moderate
the magnitude of the extinction eect. Whereas social scientists sometimes emphasize the
role that journal editors can have in shaping individual careers, life scientists are often more
17concerned that the allocation of grant dollars deviates from the meritocratic ideal. Therefore,
we investigate whether the treatment eect is of larger magnitude when the star either sat
on NIH review panels in the last 5 years, or has coauthorship ties with other scientists who
sat on study sections in the recent past. In column 1, we nd that this is not the case.
The dierential impacts are relatively small, positive in magnitude, and not statistically
signicant.
Second, we address the hypothesis that superstars matter because they broker relation-
ships between scientists that would otherwise remain unaware of each other's expertise. We
do so by computing the betweenness centrality for the extinct superstars in the coauthorship
network formed by the 10,349 elite scientists.14 We then rank the superstars according to
quartile of betweenness, and look for evidence that collaborators experience a more pro-
nounced decline in output if their superstar coauthor was more central (column 2). We nd
that collaborators with stars in the top quartile suer additional losses, relative to collabo-
rators of less central superstars, but this dierential eect is statistically insignicant.
Finally, in column 3, we look for a dierential eect of superstar death for coauthors
that were also former trainees. It is possible that mentors continue to channel resources
to their former associates even after they leave their labs, in which case one would expect
these former trainees to exhibit steeper and more precipitous declines following the passing
of their adviser. In fact, the dierential eect is large and positive, though not statistically
signicant.
The evidence presented in Table V appears broadly inconsistent with the three particular
gatekeeping stories whose implications we could test empirically. Our assessment of the
gatekeeping mechanism must remain guarded for two reasons. First, the eect of variables
used to proxy for the strength of social ties are subject to alternative interpretations. For
instance, a former trainee eect could also be interpreted as providing evidence of knowledge
spillovers, since mentorship can continue into the early faculty career and be extremely
14Betweenness is a measure of the centrality of a node in a network, and is calculated as the fraction of
shortest paths between dyads that pass through the node of interest. In social network analysis, it is often
interpreted as a measure of the inuence a node has over the spread of information through the network.
18important for a young scholar's intellectual development. Furthermore, it is possible to
think of alternative versions of the gatekeeping mechanism; as an example, superstars might
be able to curry favors with journal editors on behalf of their prot eg es, or they might be
editors themselves. We prefer to frame the ndings contrapositively: it is hard to look at
the evidence presented so far and conclude that access to resources is a potent way in which
superstars inuence their collaborators' scientic output.
Knowledge Spillovers. We now examine the possibility that stars generate knowledge
spillovers onto their coauthors. In Table VI, we build a circumstantial case for the spillover
view by documenting evidence of additional output losses for collaborators who were more
proximate with the superstar at the time of death, using two dierent meanings of proximity:
physical and intellectual.
In column 1, we investigate the impact of physical proximity by interacting the treat-
ment eect with an indicator variable for those collaborators who were co-located with the
superstar at the time of death. We nd essentially no dierence between the fates of these
coauthors and those of coauthors located further away | the interaction term is positive,
small in magnitude, and imprecisely estimated. At rst blush, this nding appears consistent
with some recent work suggesting a fading role for geographic distance, both as a factor in-
uencing the formation of teams (Rosenblat and M obius 2004; Agrawal and Goldfarb 2008),
and as a factor circumscribing the inuence of peers (Kim et al. 2006; Grith et al. 2007;
Waldinger 2008). However, our estimate of the co-location interaction term conates the ef-
fect of the loss of knowledge spillovers, the eect of the loss of help and protection provided
by the star in the competition for internal resources (such as laboratory space), and the eect
of any measure taken by the institution to compensate for the death of the superstar. As a
result, it is unclear whether our results contradict the more conventional view that spillovers
of knowledge are geographically localized (Zucker et al. 1998; Ham and Weinberg 2008).15
In column 2, we investigate whether the death of a superstar coauthor has a disparate
impact on the group of scientists who work on similar research problems. We proxy intellec-
15We thank an anonymous reviewer for making this point.
19tual distance between the superstar and his/her coauthors with our measure of normalized
keyword overlap. Coauthors in the top quartile of this measure at the time of death suer
output decreases that are particularly large in magnitude (-12.2%).16 This evidence is con-
sistent with the existence of an \invisible college" | an elite of productive scientists highly
visible in a research area, combined with a \scatter" of less eminent ones, whose attachment
to the eld may be more tenuous (de Solla Price and Beaver 1966; Crane 1972). Superstar
scientists make their eld of inquiry visible to others of lesser standing who might enter it;
they replenish their eld with fresh ideas, and their passing causes the processes of knowledge
accumulation and diusion to slow down, or even decline.
In this view, important interactions for the production of new scientic knowledge are
not rigidly constrained by geographic or social space, but also take place in an ethereal \idea
space." But is the act of formal coauthorship necessary for a scientist to be brought into
a superstar's intellectual orbit? Since our sample is composed exclusively of coauthors, we
cannot denitively answer this question. Yet, one can use the norms of authorship in the
life sciences to try to isolate collaborators whose coauthorship tie to the star is particularly
tenuous: \accidental" collaborators | those who always nd themselves in the middle of
the authorship list. As seen in column 3, these accidental collaborators do not appear to
experience net losses after the superstar's death. This suggests that full membership in the
invisible college may be dicult to secure in the absence of a preexisting social tie.
Column 4 provides evidence that the eects of physical and intellectual proximity are
independent, since combining them in the same specication does not alter their magnitudes
or statistical signicance. Finally, column 5 demonstrates that these eects are robust to
the inclusion of controls for coauthorship intensity and recency.
Table VII provides additional evidence in favor of the spillover view by examining the
relationship between the magnitude of the treatment eect and the accomplishments of the
star. We rank superstars according to two metrics of achievement: cumulative citations and
16Specications that include four dierent interactions corresponding to the four quartiles show that the
treatment eect is monotonically increasing in intellectual distance, but we do not have enough statistical
power to reject the hypothesis that the ve coecients are equal to one another.
20cumulative NIH funding, and we focus on superstars in the top quartile of either distributions
(where these quartiles are calculated using the population of 10,349 superstars in a given
year). Column (1) shows that collaborators of heavily cited superstars suer more following
the superstar's death, while column (2) shows that this is not true for collaborators of espe-
cially well-funded superstars. Column (3) puts the two eects in a single specication. Once
again, it appears that it is the star's citation impact that matters in shaping collaborators'
post-extinction outcomes, rather than his/her control over a funding empire.17 We interpret
these ndings as buttressing our argument that it is the quality of ideas emanating from
the stars, rather than simply the availability of the research funding they control, that goes
missing after their deaths. Furthermore, these results suggest that using the same empirical
strategy, but applying it to a sample of \humdrum" coauthors who die, would not uncover
eects similar in magnitude to those we observed in Table III. As such, they validate ex post
our pragmatic focus on the eect of superstars.
The overall collection of results presented above help build a circumstantial case in favor
of interpreting the eects of superstar extinction as evidence of missing spillovers. However,
they do not enable us to reject some potentially relevant versions of the gatekeeping story
| such as inuence over the editorial process in important journals, nor do they allow us to
learn about the eect on non-collaborators.
4.5 Robustness and Sensitivity Checks
The on-line appendix provides additional evidence probing the robustness of these results.
In Table W7, we interact the treatment eect with three indicators of collaborator status, to
ascertain whether some among them are insulated from the eects of superstar extinction.
Figure W3 provides evidence that the eect of superstar extinction decreases monotonically
with the age of the collaborator at the time of death, becoming insignicantly dierent
from zero after twenty ve years of career age. Table W8 performs a number of sensitivity
checks. We verify that the eect (1) is not driven by a few stars with a large number of
17Table VII eliminates from the estimation sample the collaborators of 11 superstars who are NIH intra-
mural scientists, and as such not eligible for extramural NIH funding.
21coauthors; (2) is robust to the inclusion of indicator variables for the age of the star; (3)
is not overly sensitive to our arbitrary cuto for the superstars' age at death; and (4) is
not sensitive to the problem of leakage through the coauthorship network between treated
and control collaborators. Finally, we perform a small simulation study to validate the
quasi-experiment exploited in the paper. We generate placebo dates of death for the control
collaborators, where those dates are drawn at random from the empirical distribution of
death events across years for the 112 extinct superstars. We then replicate the specication
in Table III, column 1a, but we limit the estimation sample to the set of 5,064 control
collaborators. Reassuringly, the eect of superstar extinction in this manufactured data is a
precisely estimated zero.
5 Conclusion
We examine the role of collaboration in spurring the creation of new scientic knowledge.
Using the premature and unexpected deaths of eminent academic life scientists as a quasi-
experiment, we nd that their collaborators experience a sizable and permanent decline in
quality-adjusted publication output following these events. Exploiting the rich heterogeneity
in these collaborative relationships, we attempt to adjudicate between plausible mechanisms
that could give rise to the extinction eect.
Neither a mechanical story whereby ongoing collaborative teams struggle to replace the
skills that have gone missing, nor a gatekeeping story where stars merely serve as conduits
for tangible resources are sucient to explain our results. Rather, these eects appear to
be driven, at least in part, by the existence of knowledge spillovers across members of the
research team. When a superstar dies, part of the scientic eld to which he contributed dies
along with him, perhaps because the fount of scientic knowledge from which coauthors can
draw is greatly diminished. The permanence and magnitude of these eects also suggests
that even collaborations which produce a small number of publications may have long-term
repercussions for the pace of scientic advance.
22In the end, this paper raises as many questions as it answers. It would be interesting to
know whether superstar extinction also impacts the productivity of non-coauthors proximate
in intellectual space, and in which direction. The degree to which exposure to superstar talent
benets industrial rms is also potentially important and represents a fruitful area that we
are pursuing in ongoing research. Future work could also usefully focus on identifying quasi-
experiments in intellectual space. For instance, how do scientists adjust to sudden changes in
scientic opportunities in their eld? Finally, collaboration incentives and opportunities may
be dierent when scientic progress relies more heavily on capital equipment; an examination
of the generalizability of our ndings to other elds therefore merits further attention.
Our results shed light on an heretofore neglected causal process underlying the growth
of scientic knowledge, but they should be interpreted with caution. While we measure
the impact of losing a star collaborator, a full accounting of knowledge spillovers would
require information on the benets that accrued to the eld while the star was alive. We can
think of no experiment, natural or otherwise, that would encapsulate this counterfactual.
Moreover, the benets of exposure to star talent constitute only part of a proper welfare
calculation. Scientic coauthorships also entail costs. These costs could be borne by low-
status collaborators in the form of lower wages, or by the stars, who might divert some
of their eorts towards mentorship activities. Though some of these costs might be oset
by non-pecuniary benets, we suspect that the spillovers documented here are not fully
internalized by the scientic labor market.
Finally, for every invisible college that contracts following superstar extinction, another
might expand to slowly take its place. Viewed in this light, our work does little more than








Summary Statistics for Superstar Scientists (N=112) 
 Mean  Median  Std.  Dev.  Min.  Max. 
Birth Age at Death  57.170  58  7.042  37  67 
Degree  year  1962.741  1964 10.193 1942  1984 
MD  0.420 0 0.496 0  1 
PhD  0.438 0 0.498 0  1 
MD/PhD  0.143 0 0.351 0  1 
Female  0.063 0 0.243 0  1 
U.S.  Born  0.786 1 0.412 0  1 
Nb.  of  Collaborators  47.027 37 34.716  3  178 
NIH Review Panel Membership (past 5 yrs)  0.045  0  0.207  0  1 
Nb. of Collabs. in NIH Review Panels (past 5 yrs)  1.330  1  1.657  0  7 
Career Nb. of Publications  139.607  121  91.371  25  473 
Career Nb. of Citations  8,190  6,408  7,593  435  38,941 
Career NIH Funding  $10,722,590  $8,139,397  $12,057,638  $0  $70,231,584 
Notes: Sample consists of 112 superstar life scientists who died suddenly while still actively engaged in research. See Appendix I and Section II.A for details on 
sample construction. Degree year denotes the year of the most recent degree attained by the superstar. Number of collaborators is defined as the number of distinct 
coauthors within the scientists’ cumulative stock of publications. NIH review panel membership denotes stars who were members of an NIH review panel in the five 
years prior to their death, and the number of collaborators in NIH review panels refers to the number of coauthors of each superstar who sat on NIH review panels 





Summary Statistics for Collaborators in the Year of Superstar Death 




Nb.  of  weighted  Publications  18.314 8 27.917 0  342 
Cum. Nb. of weighted Publications  327.330  187  409.098  0  3,968 
Holds  R01  grant  0.559 1 0.497 0  1 
Co-Located  0.144 0 0.351 0  1 
Career Age  23.698  23  9.963  1  59 
Elite  0.093 0 0.290 0  1 
Cum. Nb. of Coauthorships  2.734  1  4.339  1  69 
Nb. of Other Superstar Collabs.  2.746  2  3.516  0  31 
Years since first Coauthorship  10.949  10  7.901  0  42 
Years since last Coauthorship  9.275  8  7.774  0  41 
Former trainee of the star  0.070  0  0.255  0  1 
“Accidental”  Collaborator  0.076 0 0.265 0  1 
MeSH  Keyword  Overlap  0.265 0 0.162 0  1 




Nb.  of  weighted  Publications  19.068 8 31.656 0  491 
Cum. Nb. of weighted Publications  334.905  187  436.927  0  4,519 
Holds  R01  grant  0.571 1 0.495 0  1 
Co-Located  0.123 0 0.328 0  1 
Career Age  23.761  23  9.969  0  59 
Elite  0.077 0 0.266 0  1 
Cum. Nb. of Coauthorships  2.835  1  4.894  1  75 
Nb. of Other Superstar Collabs.  3.087  2  4.255  0  44 
Years since first Coauthorship  11.022  10  7.896  0  39 
Years since last Coauthorship  9.255  8  7.728  0  38 
Former trainee of the star  0.084  0  0.278  0  1 
“Accidental”  Collaborator  0.075 0 0.264 0  1 
MeSH  Keyword  Overlap  0.259 0 0.157 0  1 
Superstar Citation Count  10,228  7,239  7,952  397  34,746 
Notes: The samples consist of faculty collaborators of 112 extinct superstar life scientists an equal number of matched control coauthors. See Sections II.B and III for 
details on the sample construction and variable definitions and Appendix II for details on the matching procedure. All variables are measured as of the year of 




Impact of Superstar Death on Collaborators’ Publication Rates 





Written with others 








  (1a) (1b) (2a)  (2b) 












Log Pseudo-Likelihood  -974,285  -1,832,594  -950,864  -1,783,958 
Nb. of Obs.  153,508  294,943  153,508  294,943 
Nb. of Collaborators  5,267  10,128  5,267  10,128 
 
Notes: Estimates stem from conditional quasi-maximum likelihood Poisson specifications. Dependent variable is the total 
number of JIF-weighted articles authored by a collaborator of a superstar life scientist in the year of observation. All models 
incorporate a full suite of year effects as well as 17 age category indicator variables (career age less than -3 is the omitted 
category). Exponentiating the coefficients and differencing from one yield numbers interpretable as elasticities. For example. 
the estimates in column (1a) imply that collaborators suffer on average a statistically significant (1-exp[-0.092])=8.79% 
decrease in the rate of publication after their superstar coauthor passes away. Robust (QML) standard errors in parentheses, 
clustered at the level of the superstar. 
†p < 0.10, 
*p < 0.05, 
**p < 0.01 
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Table IV 
Collaborator Publication Rates and Imperfect Skill Substitution 





Intensity & Recency 
 All  Pubs.  Pubs. written 
with others  All Pubs.  Pubs. written 
with others  All Pubs.  Pubs. written 
with others 
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After Death × 
At least 1 coauthorship in the 













Log  Pseudo-Likelihood  -1,831,987 -1,781,742 -1,822,664 -1,775,680 -1,821,791 -1,774,167 
Nb.  of  Obs.  294,943 294,943 294,943 294,943 294,943 294,943 
Nb.  of  Collabs.  10,128 10,128 10,128 10,128 10,128 10,128 
Notes: Estimates stem from conditional quasi-maximum likelihood Poisson specifications. Dependent variable is the total number of JIF-weighted articles authored 
by a collaborator of a superstar life scientist in the year of observation. Regular and Close Collaborator are indicator variables for the number of publications 
coauthored by the superstar and colleague at the time of death (regular collaborations correspond to between 3 and 9 coauthored pubs.; close collaborations 
correspond to 10 or more coauthored pubs; casual collaborations — the omitted category — corresponds to 1 or 2 coauthored pubs.). All models incorporate year 
effects and 17 age category indicator variables (career age less than -3 is the omitted category), as well as 17 interaction terms between the age effects and each 
covariate of interest (i.e., column (3b) includes a total of 3×17=51 age-specific interaction terms). Robust (QML) standard errors in parentheses, clustered at the 
level of the superstar. 
†p < 0.10, 
*p < 0.05, 
**p < 0.01 
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Table V 
Collaborator Publication Rates and Access to Resources 
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Log  Pseudo-Likelihood  -1,831,339 -1,831,779 -1,830,582 -1,828,754 
Nb.  of  Obs.  294,943 294,943 294,943 294,943 
Nb.  of  Collabs.  10,128 10,128 10,128 10,128 
Notes: Estimates stem from conditional quasi-maximum likelihood Poisson specifications. Dependent variable is the total number of JIF-weighted articles authored 
by a collaborator of a superstar life scientist in the year of observation. Betweenness centrality is measured using the network of 10,349 superstar life scientists, 
Former trainee indicates that the colleague was a graduate student or postdoctoral fellow in the laboratory of the superstar (7.69% of the collaborators). All models 
incorporate year effects and 17 age category indicator variables (career age less than -3 is the omitted category), as well as 17 interaction terms between the age 
effects and each covariate of interest. Robust (QML) standard errors in parentheses, clustered at the level of the superstar. 
†p < 0.10, 
*p < 0.05, 
**p < 0.01 
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Table VI 
Collaborator Publication Rates and Proximity in Geographic & Intellectual Space 
 (1)  (2)  (3)  (4)  (5) 
















































































% of Collabs. Affected  13.33  25.35  7.53     
Log Pseudo-Likelihood  -1,831,900  -1,830,305  -1,831,787  -1,828,805  -1,817,667 
Nb. of Obs.  294,943  294,943  294,943  294,943  294,943 
Nb. of Collabs.  10,128  10,128  10,128  10,128  10,128 
Notes: Estimates stem from conditional quasi-maximum likelihood Poisson specifications. Dependent variable is the total number of JIF-weighted articles authored 
by a collaborator of a superstar life scientist in the year of observation. Co-located indicates that the colleague and superstar were employed at the same institution 
at the time of superstar death. Keyword overlap is the normalized number of MeSH keywords which appear on both the colleague and superstars non-joint 
publications. Accidental collaborators are those who only appear on coauthored publications with the superstar when both are in the middle of the authorship list. 
Regular and Close Collaborator are indicator variables for the number of publications coauthored by the superstar and colleague at the time of death (regular 
collaborations correspond to between 3 and 9 coauthored pubs.; close collaborations correspond to 10 or more coauthored pubs; casual collaborations — the 
omitted category — corresponds to 1 or 2 coauthored pubs.). All models incorporate year effects and 17 age category indicator variables (career age less than -3 is 
the omitted category), as well as 17 interaction terms between the age effects and the covariate of interest. Robust (QML) standard errors in parentheses, clustered 
at the level of the superstar. 
†p < 0.10, 
*p < 0.05, 
**p < 0.01 30 
Table VII 
Impact of Superstar Status on Collaborators’ Publication Rates 
  Superstar Status 
Citations 
 Superstar Status 
NIH Funding 
 Superstar Status 
Citations & NIH 
Funding 
 (1)  (2)  (3) 
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Log Pseudo-Likelihood  -1,715,929  -1,716,213  -1,715,916 
Nb. of Obs.  275,776  275,776  275,776 
Nb. of Collabs.  9,470  9,470  9,470 
Notes: Estimates stem from conditional quasi-maximum likelihood Poisson specifications. Dependent variable is the total 
number of JIF-weighted articles authored by a collaborator of a superstar life scientist in the year of observation. Top quartiles 
of citations and career NIH funding are defined using the population of 10,009 superstar scientists with appointments 
compatible with extramural NIH funding. We exclude from the estimation sample the collaborators of 11 “intramural” NIH 
scientists who are not eligible to receive extramural funding. All models incorporate year effects and 17 age category indicator 
variables (career age less than -3 is the omitted category), as well as 17 (columns (1) and (2)) or 34 (column (3)) interaction 
terms between the age effects and the “Top Quartile” indicator variable. Robust (QML) standard errors in parentheses, 
clustered at the level of the superstar. 
†p < 0.10, 
*p < 0.05, 
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terms used in the colleague’s total publications. This measure is calculated for articles published in the five years 




Dynamics of the Treatment Effect 
 
 




















Notes: The solid blue lines in the above plots correspond to coefficient estimates of conditional fixed effects quasi-maximum likelihood Poisson specifications in which the 
weighted publication output of a collaborator is regressed onto year effects, 17 indicator variables corresponding to different age brackets, and interactions of the treatment 
effect with 27 indicator variables corresponding to 11 years before the year of death and prior, 10 years before the year of death, 9 years before the year of death,…, 14 years 
after the year of death, and 15 years after the year of death and above (the indicator variable for treatment status interacted with the year of death is omitted). The 95% 
confidence interval (corresponding to robust standard errors, clustered around superstars) around these estimates is plotted with dashed red lines. Figure IIIA uses column (1b) 
of Table III as a baseline (i.e., treated and control collaborators, the dep. var. includes all of the collaborator’s publications); Figure IIIB uses column (2b) of Table III as a 






Criteria for Delineating the Set of 10,349 \Superstars"
We present additional details regarding the criteria used to construct the sample of 10,349 superstars.
Highly Funded Scientists. Our rst data source is the Consolidated Grant/Applicant File (CGAF) from
the U.S. National Institutes of Health (NIH). This dataset records information about grants awarded to
extramural researchers funded by the NIH since 1938. Using the CGAF and focusing only on direct costs
associated with research grants, we compute individual cumulative totals for the decades 1977-1986, 1987-
1996, and 1997-2006, deating the earlier years by the Biomedical Research Producer Price Index.18 We also
recompute these totals excluding large center grants that usually fund groups of investigators (M01 and P01
grants). Scientists whose totals lie in the top ventile (i.e., above the 95th percentile) of either distribution
constitute our rst group of superstars. In this group, the least well-funded investigator garnered $10.5
million in career NIH funding, and the most well-funded $462.6 million.19
Highly Cited Scientists. Despite the preeminent role of the NIH in the funding of public biomedical
research, the above indicator of \superstardom" biases the sample towards scientists conducting relatively
expensive research. We complement this rst group with a second composed of highly cited scientists
identied by the Institute for Scientic Information. A Highly Cited listing means that an individual was
among the 250 most cited researchers for their published articles between 1981 and 1999, within a broad
scientic eld.20
Top Patenters. We add to these groups academic life scientists who belong in the top percentile of the
patent distribution among academics | those who were granted 17 patents or more between 1976 and 2004.
Members of the National Academy of Sciences. We add to these groups academic life scientists who
were elected to the National Academy of Science between 1975 and 2007.
MERIT Awardees of the NIH. Initiated in the mid-1980s, the MERIT Award program extends fund-
ing for up to 5 years (but typically 3 years) to a select number of NIH-funded investigators \who have
demonstrated superior competence, outstanding productivity during their previous research endeavors and
are leaders in their eld with paradigm-shifting ideas." The specic details governing selection vary across
the component institutes of the NIH, but the essential feature of the program is that only researchers holding
an R01 grant in its second or later cycle are eligible. Further, the application must be scored in the top
percentile in a given funding cycle.
Former and current Howard Hughes Medical Investigators. Every three years, the Howard Hughes
Medical Institute selects a small cohort of mid-career biomedical scientists with the potential to revolutionize
their respective subelds. Once selected, HHMIs continue to be based at their institutions, typically leading
a research group of 10 to 25 students, postdoctoral associates and technicians. Their appointment is reviewed
every ve years, based solely on their most important contributions during the cycle.21
Early career prize winners. We also included winners of the Pew, Searle, Beckman, Rita Allen, and
Packard scholarships for the years 1981 through 2000. Every year, these charitable foundations provide seed
funding to between 20 and 40 young academic life scientists. These scholarships are the most prestigious
accolades that young researchers can receive in the rst two years of their careers as independent investigators.
18http://officeofbudget.od.nih.gov/UI/GDPFromGenBudget.htm
19We perform a similar exercise for scientists employed by the intramural campus of the NIH. These scientists are not eligible
to receive extramural funds, but the NIH keeps records of the number of \internal projects" each intramural scientist leads. We
include in the elite sample the top ventile of intramural scientists according to this metric.
20The relevant scientic elds in the life sciences are microbiology, biochemistry, psychiatry/psychology, neuroscience, molec-
ular biology & genetics, immunology, pharmacology, and clinical medicine.
21See Azoulay et al. (2009) for more details and an evaluation of this program.
33Appendix II: Construction of the Control Group
We detail the procedure implemented to identify the control collaborators that help pin down the life-cycle
and secular time eects in our dierence-in dierence (DD) specication. Because it did not prove possible
to perfectly match treated and control collaborators on all covariates, the procedure is guided by the need
to guard against two specic threats to identication.
First, collaborators observed in periods before the death of their associated superstar are more likely to work
with a younger superstar; thus, they are not ideal as a control if research trends of collaborators dier by
the age of the superstar. Collaborators observed in periods after the death of their associated superstar are
only appropriate controls if the death of their superstar only aected the level of their output; if the death
also negatively aected the trend, xed eects estimates will be biased towards zero.
Second, xed eects estimates might be misleading if collaborations with superstars are subject to idiosyn-
cratic dynamic patterns. Happenstance might yield a sample of stars clustered in decaying scientic elds.
More plausibly, collaborations might be subject to specic life-cycle patterns, with their productive potential
rst increasing over time, eventually peaking, and thereafter slowly declining. Relying solely on collaborators
treated earlier or later as as an implicit control group entails that this dyad-specic, time-varying omitted
variable will not be fully captured by collaborator age controls.
To address these threats, the sample of control collaborators (to be recruited from the universe of collabo-
rators for the 10,000 stars who do not die prematurely, regardless of cause) should be constructed such that
the following four conditions are met:
1. treated collaborators exhibit no dierential output trends relative to control collaborators up to the
time of superstar death;
2. the distributions of career age at the time of death are similar for treated and controls;
3. the time paths of output for treated and controls are similar up to the time of death;
4. the dynamics of collaboration up to the time of death | number of coauthorships, time elapsed since
rst/last coauthorship, superstar's scientic standing as proxied by his cumulative citation count |
are similar for treated and controls.
Coarsened Exact Matching. To meet these goals, we have implemented a \Coarsened Exact Matching"
(CEM) procedure (Iacus et al. 2008) to identify a control for each treated collaborator. As opposed to
methods that rely on the estimation of a propensity score, CEM is a non-parametric procedure. This seems
appropriate given that we observe no covariates that predict the risk of being associated with a superstar
scientist who dies in a particular year.
The rst step is to select a relatively small set of covariates on which the analyst wants to guarantee
balance. In our example, this choice entails judgement, but is strongly guided by the threats to identication
mentioned above. The second step is to create a large number of strata to cover the entire support of the
joint distribution of the covariates selected in the previous step. In a third step, each observation is allocated
to a unique strata, and for each observation in the treated group, a control observation is selected from the
same strata; if there are multiple choices possible, ties are broken randomly.
The procedure is coarse because we do not attempt to precisely match on covariate values; rather, we coarsen
the support of the joint distribution of the covariates into a nite number of strata, and we match a treated
observation if and only if a control observation can be recruited from this strata. An important advantage
of CEM is that the analyst can guarantee the degree of covariate balance ex ante, but this comes at a cost:
the more ne-grained the partition of the support for the joint distribution (i.e., the higher the number of
strata), the larger the number of unmatched treated observations.
Implementation. We identify controls based on the following set of covariates (t denotes the year of death):
collaborator's degree year, number of coauthorships with the star at t, number of years elapsed since last
34coauthorship with the star at t, JIF-weighted publication ow in year t, cumulative stock of JIF-weighted
publications up to year t   1, and the star's cumulative citation count at t. We then coarsen the joint
distributions of these covariates by creating 51,200 strata. The distribution of degree years is coarsened
using three year intervals; the distribution of coauthorship intensity is coarsened to map into our taxonomy
of casual (1 and 2 coauth.), regular (between 3 and 9 coauth.), and close collaborators (10 or more coauth.);
the distribution of coauthorship recency is coarsened into quartiles (the rst quartile corresponds to recent
relationships, i.e. less than 3 years since the last coauthorship); the ow of publications in the year of death
is coarsened into 5 strata (the three bottom quartiles; from the 75th to the 95th percentile, and above the
95th percentile); the stock of publications is coarsened into eleven strata (0 to 5th; 5th to 10th; 10th to 25th;
25th to 35th; 35th to 50th; 50th to 65th; 65th to 75th; 75th to 90th; 90th to 95th; 95th to 99th; and above the
99th percentile); and the distribution of citation count for the star is coarsened into quartiles.
We implement the CEM procedure year by year, without replacement. Specically, in year t, we:
1. eliminate from the set of potential controls all superstars who die, all coauthors of superstars who die,
and all control coauthors identied for years of death k;1979  k < t;
2. create the strata (the values for the cuto points will vary from year to year for the some of the
covariates mentioned above);
3. identify within strata a control for each treated unit; break ties at random;
4. repeat these steps for year t + 1.
We match 5,064 out of 5,267 treated collaborators (96.15%). In the sample of 5;064 treated+5;064 controls=
10;128 collaborators, there is indeed no evidence of prexisting trends in output (Figure A1); nor is there
evidence of dierential age eects in the years leading up to the death event (Figure A2). As seen in
Table II, treated and controls are very well-balanced on all covariates that pertain to the dynamics of the
collaboration: number of coauthorships, time since last and rst coauthored publication, and superstar's
citation count. The age distributions are very similar as well. Furthermore, the CEM procedure balances
a number of covariates that were not used as inputs, such as normalized keyword overlap and R01 NIH
grantee status. For some covariates, we can detect statistically signicant mean dierences, though they do
not appear to be substantively meaningful (e.g., 7% of controls vs. 8.4% of treated collaborators were former
trainees of their associated superstars).
Sensitivity Analyses. The analyst's judgement matters for the outcome of the CEM procedure insofar as
she must draw a list of \reasonable" covariates to match on, as well as decide on the degree of coarsening to
impose. Therefore, it is reasonable to ask whether seemingly small changes in the details have consequences
for how one should interpret our results.
Non-parametric matching procedures such as CEM are prone to a version of the \curse of dimensionality"
whereby the proportion of matched units decreases rapidly with the number of strata. For instance, requiring
a match on an additional indicator variable (i.e., doubling the number of strata from around 50,000 to
100,000) results in a match rate of about 70%, which seems unacceptably low. Conversely, focusing solely on
degree age and the ow and stock of the outcome variables would enable us to achieve pairwise balance (as
opposed to global balance, which ignores the one-to-one nature of the matching procedure) on this narrower
set of covariates, but at the cost of large dierences in the features of collaborations (such as recency and
intensity) between treated and controls. This would result in a control sample that could address the rst
threat to identication mentioned above, but not the second.
However, we have veried that slight variations in the details of the implementation (e.g., varying slightly
the number of cuto points for the stock of publications; focusing on collaboration age as opposed to
collaboration recency; or matching on superstar funding as opposed to superstar citations) have little impact
on the results presented in Table III. To conclude, we feel that CEM enables us to identify a population





Figure A1: Publication Trends for Treated and Control Collaborators 
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Note: Each dot cooresponds to the coefficient estimate for the interaction between an age indicator variable and 
treatment status in a Poisson regression of weighted publications onto a full suite of year effects, a full suite of 
age effects, and age by treatment status interaction terms. The population includes control and treated 
collaborators, but the estimation sample is limied to the years before the death of the associated superstar. The 
blue vertical brackets denote the 95% confidence interval (corresponding to robust standard errors, clustered 
around collaborators) around these estimates. 
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I | Matching Superstars and Collaborators
We designed the Stars/Colleague Generator (S/CGen) to harvest coauthors' names from a superstar's
bibliome. S/CGen identies colleagues to the extent that (a) they coauthor at least once; and (b) they can
be matched (based on a combination of a last name and up to two initials) with the AAMC Faculty Roster.
We will describe the matching process using as an example one of our extinct superstars, Jerey M. Isner,
MD. Isner, a pioneer of gene therapy for Peripheral Artery Diseases, and a faculty member at the Tufts
University School of Medicine, died in 2001 from a heart attack, at the age of 54.
The matching process begins with the creation of a customized PubMED search query for each superstar. In
the case of Isner, the query is ("isner jm"[au] OR "isner j"[au]) AND 1977:2006[dp], and it returns
373 original publications (the query also returns 24 letters, editorials, interviews, etc., which we ignore).
The process of harvesting bibliomes from PubMED using name variations and queries as inputs is facilitated
by the use of PubHarvester, a software program we specically designed for this purpose (Azoulay et al.
2006).
Spurious Coauthors. Je Isner's PubMED query accounts for his inconsistent use of the middle initial, but
is otherwise quite simple. For other scientists, queries might factor in their inconsistent use of the sux \Jr.,"
or name variations coincident with changes in marital status. For yet many others with frequent names,
the queries are more involved, and make use of CV information such as scientic keywords, institutional
aliation, frequent coauthors' names, etc. This is essential, since errors of commission will tend to generate
spurious coauthor matches. We guarded against this source of error by devoting hundreds of person-hours
to the design of accurate search queries for each of our 10,349 superstars. This degree of labor-intensive
customization ensures that a superstar's bibliome excludes publications belonging to homonymous scientists.
Matching process. The second step is to extract the name of coauthors from the star's bibliome and to
match them with the AAMC Faculty Roster. Unfortunately, PubMED does not record authors' full names,
nor does it record their institutional aliations; it only keeps track of authors by using a combination of last
name, two initials, and a sux (where the sux and the second initial elds can be empty). The matching
process is automated by SC/Gen, and its outcome in the case of a sample publication authored by Je
Isner is illustrated in Figure W1. S/CGen cannot generate a match for each coauthor. Some coauthors
are technicians or undergraduate students; others are graduate students or postdocs who do not go on to
faculty positions; yet others are located in foreign institutions; others still publish under names that dier
from the Faculty Roster listing (for instance by being inconsistent with the use of middle initials, suxes,
or hyphens). In total, SC/Gen generates 355 matches with the AAMC Faculty Roster for Isner.
Ambiguous Coauthors. Often, SC/Gen can match a given PubMED name with more than one faculty in
the Roster. Notice the case of ramaswamy k on Figure W1. Does it correspond to K. Ramaswamy (University
of Illinois{Chicago), to Karthik Ramaswamy (UMASS School of Medicine), or to Krishna Ramaswamy (Tufts
University School of Medicine)? Several options are available to deal with these ambiguous matches. We
could discard the rst two matches, since the third one corresponds to an individual who shared Isner's
institutional aliation. Alternatively, we could retain all three matches, but assign each a weight of 1
3,
incorporating a guess on the probability that each match is genuine. Finally, we could simply discard all
three matches, and focus instead on those matches that are unambiguous. This is the approach we have
followed to generate the results we present in the paper.1 Out of the 355 matches mentioned above, only
1Trajtenberg et al. (2006) propose algorithms to automate the process of name disambiguation in patent data. Adapting
their approach to publication data lies far beyond the scope of this paper. To x ideas, Lechleiter JD is an example of unique
i177 correspond to coauthors with unambiguous PubMED names. For the set of 112 superstars, S/CGen
identies 5,267 distinct coauthors with unambiguous PubMED names | an average of 47 coauthors per
superstar (the median is 37).
Coauthors' Publication Output. The publication output of coauthors with frequent names will be
measured with error. This source of error is less worrisome, since it involves a dependent variable. Nonethe-
less, we have taken several steps to ascertain the extent to which it biases our results. First, our decision
to eliminate from the sample coauthors with ambiguous PubMED names means that it is almost entirely
composed of individuals with relatively rare names. Second, we have experimented with deleting from the
estimation sample observations corresponding to coauthors with unique PubMED names, but popular last
names.2 Specically, we dropped from the main analysis all coauthors whose last name appear 160 or more
times in the roster (the 99th percentile of the distribution of last name frequency, which correspond to names
such as Greenwald, McKee, O'Malley, or Fu). This hardly aected the main results. Third, we limit the
estimation sample to elite coauthors (i.e., coauthors who belong to the set of 10,349 \superstars"). Because
we designed custom PubMED queries for these individuals, their output is measured with little (if any) error.
The magnitude of the treatment eect is very similar to the one obtained on the full sample of coauthors.
II | Measuring Proximity in Ideas Space
We describe the construction of our variable to measure distance (or rather, proximity) in intellectual or
\ideas space" between nodes in a dyad of scientists. The boundaries around scientic elds are dicult to
delineate since most scientic research can be classied in numerous ways, and agreement among scientists
regarding the categorization of specic bits of knowledge is often elusive. Our approach is predicated on the
inadequacy of measures based on shared department aliation, or on coarse distinctions between scientic
elds (e.g., cell vs. molecular biology). Instead of attempting to position individual scientists relative to
some xed address in ideas space, we provide a method to cheaply and conveniently measure relative position
in this space.
An essential input is provided by the Medical Subject Headings (MeSH) thesaurus, a controlled vocabu-
lary produced by the National Library of Medicine whose explicit statement of purpose is to \provide a
reproducible partition of concepts relevant to biomedicine for the purpose of organizing knowledge and in-
formation." The MeSH vocabulary consists of 24,767 terms arranged in a hierarchical structure, and these
terms are used by NLM sta to tag all the articles indexed by the PubMED database.3 From our standpoint,
one of the MeSH system's most attractive feature is its ne-grained level of detail. For instance, the initial
draft of the public human genome project (Lander et al. 2001) is tagged by 26 distinct descriptors, which run
the gamut from the very general (\Humans", \RNA/Genetics") to the very specic (\Repetitive Sequences,
Nucleic Acid", \CpG Islands", \DNA Transposable Elements").4
The procedure followed to generate our dyadic measure of intellectual proximity is best explained through
a concrete example. We will focus on a two scientists, Andrew Schally (from Tulane University in New
Orleans, LA) and Roger Guillemin (from the Salk Institute in San Diego, CA). Throughout the 1960s and
1970s, this pair of eminent neuro-endocrinologists was locked in a very public (and often acrimonious) rivalry
PubMED name. In contrast, Weinstein SL corresponds to two distinct faculty in the roster, Miller MJ to ten, and Wang Y to
thirty six.
2For instance, Miller CR is a unique PubMED name, though Miller is the last name for 800 distinct individuals in the
AAMC Faculty Roster.
3At the highest level of the hierarchical structure are very broad headings such as \Anatomy" or \Mental Disorders."
More specic headings are found at lower levels of the eleven-level hierarchy, such as \Ankle" and \Conduct Disorder." See
http://www.nlm.nih.gov/mesh/ for more details.
4This stands in sharp contrast to the coarse partition of technological space provided by patent classes, which are often
used in the study of involuntary knowledge spillovers (Benner and Waldfogel 2007).
iiwhose ultimate goal was the synthesis of peptide hormones produced by the brain. Together with Rosalyn
Yalow, the Nobel committee awarded them both the Prize in Medicine and Physiology in 1977 (details of
this celebrated case of a scientic race can be found in Nicholas Wade's The Nobel Duel). We will focus on
the ve-year window that preceded the award of the Prize, i.e., 1973-1977. During this period, Guillemin
and Schally did not collaborate at all, and according to Wade (1981), even actively sought to undermine
each other's progress.
The calculation is illustrated in Table W2; it is automated by SciDist, an open-source software program we
specically designed for this purpose.5 Between 1973 and 1977, Schally published 240 articles, and Guillemin
\only" 60. We extract from these publications all MeSH terms, regardless of their position in the descriptor
hierarchy. There are a total of 607 unique MeSH terms tagging the two scientists' publications, 147 of which
overlap. Table W2 lists the Top 10 overlapping terms with highest and lowest combined use, respectively.6
To compute the proximity of Guillemin to Schally, we simply divide the number of overlapping MeSH terms
(147), by the total number of unique MeSH terms tagging Guillemin's 60 publications (220). In contrast, the
proximity of Schally to Guillemin is given by 147 divided by 534 (the total number of unique MeSH terms
tagging Schally's 240 publications). We view this lack of symmetry as an attractive feature of our approach,
since Schally's research agenda during this period was signicantly broader, and in fact encompassed most
of Guillemin's. In contrast, many of the distance concepts used to date in the literature | for example
to position rms' research portfolio in technology space | use an Euclidean (hence symmetric) concept of
distance (e.g., Jae 1986).
III | Pre-existing Trends in Output for the Superstars
In Table W3, we present results for specications in which the superstars' quality-adjusted publication output
is regressed onto a series of indicator variables corresponding to the timing of death: 5 years before the year
of death, 4 years before the year of death, and so on, up until two years after the year of death (a scientist
can, and often does, publish after his death because his/her coauthors will typically steward articles through
the pipeline on his behalf). All models include superstar scientist xed eects, and we use as a control group
the set of superstars who collaborate with the sample of control collaborators. The inclusion of controls is
important insofar as it enables us to pin down the eect of age and calendar time, which might be correlated
with the death eect.
We use two denitions of the dependent variable. In the rst (column 1), all of the stars' publications
participate in the calculation of the JIF-weighted count; in the second (column 2), only the publications in
which the star appears in last position on the authorship roster are considered (last author status is reserved
to the heads of laboratory/research group in the life sciences). In both specications, we nd no evidence
that the superstars' output trends downward even before their death. In fact, the coecient estimates turn
negative in sign only in the year that follows the year of death, and reach statistical signicance only two
years after the death. In light of these results, we feel condent that our informal screen for research activity
yields a set of 112 extinct superstars still actively engaged in science at the time of their deaths.
5SciDist is available for download at http://www.stellman-greene.com/ScientificDistance/.
6An open question is whether one should weight each term by its frequency of use, or whether it is the number of unique terms
that matters. In practice, these alternatives yield two measures of proximity that are heavily correlated, and the distinction
does not aect the substance of our results.
iiiIV | Main Results with OLS Estimation
In Table W4, we replicate the results in Table III using linear collaborator xed eects specications.
This robustness check is informative insofar as linear specications enable us to completely saturate the
specications with age eects (a total of 54 indicator variables, vs. 17 in the QML Poisson specications
presented in the main body of the paper). The results in column 1a imply that coauthors suer a 1.55
yearly decline in JIF-weighted publication output following the death of their superstar collaborator. This
represents a 8.14% decrease relative to the mean of the dependent variable at the time of death. In contrast,
the estimate of the treatment eect in column 1a of Table III corresponds to a 8.79% decline in the JIF-
weighed publication rate. The magnitudes observed in colums 1b through 2b in Table III and W4 are likewise
very similar.
V | Publication-level Quality Adjustment using Citation Data
The quality adjustment used to produce JIF-weighted publication counts is crude. It does not allow us
to learn whether the research that does not get published as a consequence of superstar death is more
likely to be of great vs. marginal signicance. Table W5 answers this question by modeling the eect of
superstar extinction for the production of articles falling above various quantiles of the citation distribution.
An important caveat is that the results pertain only to the set of 1,436 controls+1;416 treated=2;852
collaborators who are also part of our elite group of 10,349 scientists, since this is the set for which article-
level citation data is available. These 2,852 scientists account for 28.16% of the collaborators in the overall
sample.
Citation data suer from a well known truncation problem: older articles have had more time to be cited,
and hence are more likely to reach the tail of the citation distribution, ceteris paribus. To overcome this
issue, we compute a dierent empirical cumulative distribution for the article-level distribution of citations
in each publication year.7 For example, in the life sciences broadly dened, an article published in 1980
would require at least 98 citations to fall into the top ventile of the distribution; an article published in 1990,
94 citations; and an article published in 2000, only 57 citations (this is illustrated in Figure W2). With these
empirical distributions in hand, it becomes meaningful to count the number of articles that fall, for example,
in the top quartile of citations for a given scientist in a particular year. These counts in turn provide the
dependent variables used in Table W5.
We begin by replicating the results of Table III, Model 2b on this restricted set of collaborators. The
treatment eect is slightly lower in magnitude, but remains highly statistically signicant (column 1). The
same result obtains when using the raw (i.e., not JIF-weighted) number of publications as the outcome
variable (column 2). We then nd that the magnitude of the treatment eect increases as one restricts the
dependent variable to publications that fall in higher quantiles of the citation distribution. It hovers between
-6 and -9% when we examine the eect of superstar extinction on publications that fall in the bottom quartile,
below the median, above the median, or in the top quartile of the citation distribution. It increases to -9%
for publications in the top ventile, and still further to -15% when focusing on \blockbuster" publications |
those falling in the top percentile of the citation distribution. At the very least, these results suggest that
superstar exposure is not limited to the production of relatively less signicant scientic knowledge.
7We thank Stefan Wuchty and Ben Jones from Northwestern University for performing the computations. These vintage-
specic distributions are not based on in-sample article data, but use the universe of articles published since 1970 in biomedical
and chemical journals indexed by the Web of Science.
ivVI | Eect of Superstar Extinction on Receipt of NIH Funding
We present evidence on the eect of superstar extinction on receipt of NIH funding. Grants are typically
awarded for a period of years (three to ve is typical), and disbursed in equal yearly amounts over this period.
Only the rst of these payments is indicative of successful grantsmanship. We exclude from the calculation
non-research grants (fellowships, training grants, and infrastructure grants), as well as large center research
grants. The CGAF dataset only lists principal investigators (PIs) for each grant; as a result, we are unable
to separate the grants in which coauthor and superstars are co-investigators from those that do not entail
a formal research collaboration. This limitation must be borne in mind when interpreting the results of
specications relying on grant data. We also eliminate from the estimation sample 318 treated and 260
control collaborators who are NIH employees at some point during their career, and as such not eligible for
receipt of extramural NIH funding.
Table W6 presents the results, using two dierent dependent variables: the number of research grants
(columns 1a and 1b), and the probability of receiving at least one grant in a given year (columns 2a and 2b).
The rst two models are estimated using conditional collaborator xed eects quasi-maximum likelihood.
In these specications, the 3,669 collaborators (38.72% of the controls vs. 36.55% of the treated) who never
receive a grant during the observation period drop out of the observation sample. The last two models are
estimated using a collaborator xed eects linear probability model, on the entire sample of grant-eligible
collaborators, including 37% among them who never receive (and may not even have applied for) a grant
from the NIH.
The magnitudes of the eects in columns 1a and 1b are strikingly similar to those observed for publication
output, though they are only statistically signicant at the 10% level. In contrast, the magnitudes of the
extinction eect for the linear probability models are quite small: they suggest that the probability of
receiving a grant falls by a statistically signicant 1% after the scientist loses a superstar collaborator. We
must interpret these results with caution: there is obviously large heterogeneity in the quality and importance
of research grants, and our dependent variable does not account for this.
VII | Treatment Eect Heterogeneity: Impact of Collaborator
Status and Age at the Time of Superstar Death
In Table W7, we interact the treatment eect with three indicators of collaborator status, to ascertain whether
some among them are insulated from the eects of superstar extinction documented earlier. Column 1
focuses on faculty members whose sole elite collaborator was the superstar who died. For these coauthors
with relatively poor substitution opportunities (they account for roughly 27.66% of the dyads in the sample),
the consequences of the superstar's loss are particularly severe, with an overall 15.3% decline in publication
output. Columns 2 asks whether scientists who are PIs on a NIH R01 grant at the time of their superstar
coauthor's death are shielded from the adverse eects documented earlier. With independent funding of this
type, these investigators (who account for more than half of the sample) are likely to be less dependent on
the goodwill of their collaborators, but we nd no evidence supporting this conjecture: the dierential eect
is an small and imprecisely estimated; Independent NIH funding is not enough to insulate scientists from the
loss of an eminent collaborator. In column 3, we present evidence that the \elite among the elite" (members
of the National Academy of Science, Howard Hughes Medical Investigators, and NIH MERIT awardees who
together account for 8.5% of the total number of collaborators) is relatively unaected by the loss of a \peer
superstar." The dierential impact on elite coauthors is positive, large, and statistically signicant; it osets
almost exactly the main treatment eect.
We conclude that the eect of superstar extinction is heterogeneous with respect to coauthor status, but the
heterogeneity stems from the tails of the status distribution. The loss of a prominent collaborator adversely
vimpacts the productivity of investigators even if they are independently funded, unless they have already
achieved great renown at the time of the star's death.8
We also investigate whether the magnitude of the treatment eect varies with the collaborator's age at
the time of death for the superstar. To do so, we interact the treatment eect with 8 indicator variables
corresponding to dierent career age brackets: 5 to 10 years, 10 to 15 years, 15 to 20 years, 20 to 25 years,
25 to 30 years, 30 to 35 years, 35 to 40 years, and more than 40 years of career age at death. We then plot
the corresponding coecient estimates in Figure W3, along with their 95% condence interval. The eect
decreases monotonically with the age of the collaborator at death, becoming insignicantly dierent from 0
after twenty ve years of career age. Therefore, researchers appear particularly vulnerable to the loss of a
superstar coauthor in the early part of their scientic career.
VIII | Robustness Checks
In Table W8, we present the results of a number of robustness checks, using Model (1b) of Table III as a
benchmark specication. In column 2, we examine whether a small number of stars with many collaborators
drive the main results. We drop all collaborators for the 7 superstars with the highest number of collaborators
(120 or more) from the estimation sample. The magnitude of the treatment eect drops only slightly, and
remains highly statistically signicant. In column (3), we add to the specication 10 indicator variables for
the superstar's imputed career age. This decreases the magnitude of the treatment eect by from -0.086 to
-.066. In columns (4a) and (4b), we explore the sensitivity of our results to changes in our arbitrary age
cuto for the the superstar's age at death. In (4a), we limit the sample to 71 stars who were 60 years old
or younger at the time of their death. This results in an even higher magnitude for the extinction eect
(-.113 instead of -.092). In contrast, we obtain a much smaller magnitude (-0.051) when we focus on the
collaborators of 38 eminent scientists who die beyond the creative stages of their career | at 75 years of age
or older (column 4b). This eect is also imprecisely estimated.
We then examine the possibility that our control group is contaminated because some of the control col-
laborators are separated from treated collaborators by a only few degrees in the coauthorship network.
Specically, we keep in the estimation sample only those scientists that are at least 3 degrees apart in the
coauthorship network formed by all 10,349 superstars. These scientists represent 75% of the overall sample.
In column 5, we nd that the treatment eect increases in magnitude, which is consistent with the hypothesis
that the eect of superstar extinction extends beyond the set of direct coauthors, but decays quickly with
social distance.
Finally, we perform a small simulation study to validate the quasi-experiment exploited in the paper (col-
umn 6). We generate placebo dates of death for the control collaborators, where those dates are drawn at
random from the empirical distribution of death events across years for the 112 extinct superstars. We then
replicate the specication in Table III, column 1a, but we limit the estimation sample to the set of 5,064
control collaborators. Reassuringly, the eect of superstar extinction in this manufactured data (based on
500 replications) is a precisely estimated 0.
8As seen in Table W5, taken as a whole, the set of elite coauthors suers a decline in output similar to the one observed
for the universe of all coauthors (i.e., in Table III). At the risk of repeating ourselves, the elite sample is very heterogeneous,
and does include young, old, and fading stars.
viIX | Main Results for Anticipated Death
In Table W9 and Figure W4, we present some results pertaining to the 6,515 collaborators of 136 superstars
who died prematurely, but whose particular circumstances imply that their passing was anticipated. The
vast majority of these anticipated deaths are due to cancer. Since coauthors might alter their collaboration
strategies even before the superstar's death, the case for exogeneity of the extinction event is weaker in this
case.9
The results in Table W9 parallel exactly those presented in Table III. We nd that the treatment eect
is of lower magnitude than in the sudden case (especially when the estimation sample includes control
collaborators), and less precisely estimated. We also nd very little evidence of impact on the publication
output without the superstar (columns 2a and 2b). Figure W4 mirrors Figure IIIA. The trajectory of output
appears to begin its monotonic decline prior the superstar's death (though the corresponding interaction
terms are very small in magnitude, and statistically insignicant). The treatment eect, though consistently
negative in sign, reaches statistical signicance only in the long run | 10 years or so after the superstar's
death.
These ndings suggest that collaborators and quite possibly the superstar him/herself adjust their behavior in
anticipation of the star's impending death. Though the determinants and particular form of these endogenous
responses are certainly worthy of study, they are beyond the scope of the present paper.
X | An Alternative Interpretation
Based on a Sociological Mechanism:
Ascription
Sociological studies of the scientic reward system have provided some evidence supporting the existence of
the \Matthew Eect,"10 whereby scientists receive dierential recognition for a particular scientic contribu-
tion depending on their location in the status hierarchy (Merton 1968; Cole 1970). It is possible that editors
and reviewers ascribe positive qualities to research they are charged with evaluating because of the mere
presence of the superstar's name on the authorship roster, regardless of the contribution's intrinsic merits.
The relevance of this dynamic in our setting is doubtful for two reasons. First, we observe a decline in
the output written independently of the star (Table III); second, the treatment eect is not driven by the
collaborators who have recent, or many collaborations; third, its onset is delayed until after the death of the
star. These facts argue against an interpretation of the eect based on ascription.
9Most of the anticipated deaths are due to conditions with relatively short life expectancies; those with longer ones are not
necessarily viewed as terminal until the nal stages. Six scientists who died from a neurodegenerative disease constitute an
exception. They were included in the sample because their obituaries implied they had remained actively engaged in research
until a short period before their death. We veried that our results are robust to the omission of these six superstars.
10\For unto every one that hath shall be given, and he shall have abundance; but from him that hath not shall be taken away
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Henry G. Kunkel (1916-1983) MD complications after vascular surgery Rockefeller University identification of MHC Class II molecules
John P. Merrill (1917-1984) MD drowned Harvard Medical School/Brigham & Women’s Hospital role of the immune system in kidney transplantation
Merton F. Utter (1917-1980) PhD heart attack Case Western Reserve University School of Medicine structure and function of pep carboxykinase isozymes
Abraham I. Braude (1917-1984) MD/PhD heart attack UCSD pathogenesis and treatment of life-threatening septic shock
E. Jack Wylie (1918-1982) MD heart attack UCSF development of techniques for the treatment and management of chronic visceral ischemia
Abraham M. Lilienfeld (1920-1984) MD heart attack Johns Hopkins University School of Public Health epidemiological methods for the study of chronic diseases
Sidney Riegelman (1921-1981) PhD drowned while scuba diving UCSF intersubject variation in first pass effect of drugs
Susumu Hagiwara (1922-1989) PhD bacterial infection UCLA evolutionary and developmental properties of calcium channels in cell membranes
Lucille S. Hurley (1922-1988) PhD complications from open heart surgery University of California — Davis genetic and nutritional interactions in development
Lewis W. Wannamaker (1923-1983) MD heart attack University of Minnesota Medical School clinical and epidemiologic aspects of streptococcal infections
Eugene C. Jorgensen (1923-1981) PhD murdered UCSF structure/activity relationships of compounds related to thyroxin
James M. Felts (1923-1988) PhD heart failure UCSF synthesis and processing of plasma lipoproteins
Josiah Brown (1923-1985) MD tragic accident UCLA biochemical studies of lipid and carbohydrate metabolism
Thomas R. Johns, 2nd (1924-1988) MD refractory arrhythmia University of Virginia School of Medicine physiological studies of myasthenia gravis
Robert J. Stoller (1924-1991) MD killed by a reckless teenage driver UCLA clinical studies of gender identity
Lucien J. Rubinstein (1924-1990) MD ruptured intracranial aneurysm University of Virginia School of Medicine differentiation and stroma-induction in neural tumors
William H. Oldendorf (1925-1992) MD complications from heart disease UCLA x-ray shadow radiography and cerebral angiography
Margaret O. Dayhoff (1925-1983) PhD heart attack Georgetown University Medical Center computer study of sequences of amino acids in proteins
Norman Geschwind (1926-1984) MD heart attack Harvard Medical School/Beth Israel Medical Center relationship between the anatomy of the brain and behavior
Norbert Freinkel (1926-1989) MD heart attack Northwestern University metabolic regulation in normal and diabetic pregnancies
Edward V. Evarts (1926-1985) MD heart attack NIH electrophysiological activity of in vivo neurons in waking and sleeping states
Zanvil A. Cohn (1926-1993) MD aortic dissection Rockefeller University macrophage in cell biology and resistance to infectious disease
Daniel Rudman (1927-1994) MD complications from brain surgery Medical College of Wisconsin adipokinetic substances of the pituitary gland
Gerald P. Rodnan (1927-1983) MD complications after vascular surgery University of Pittsburgh renal transport if uric acid and protein
Gustavo Cudkowicz (1927-1982) MD brief illness SUNY Buffalo controls of proliferation specific for leukemias
Gerald D. Aurbach (1927-1991) MD hit in a head by a stone NIH bone metabolism and calcium homeostasis
George Streisinger (1927-1984) PhD scuba-diving accident University of Oregon genetic mutations and the nervous system development in lower vertebrates
Carl Monder (1928-1995) PhD brief illness, acute fulminating leukemia Population Council corticosteroid metabolism in juvenile hypertension
Lucien B. Guze (1928-1985) MD sudden cardiac arrest UCLA pathogenesis of experimental pyelonephritis
Edgar C. Henshaw (1929-1992) MD complications from early-stage cancer treatment University of Rochester intermediary metabolism in animals and in man
Donald J. Magilligan, Jr. (1929-1989) MD short illness Henry Ford Health Sciences Center natural history and limitations of porcine heart valves
Lubomir S. Hnilica (1929-1986) PhD automobile accident Vanderbilt University nuclear antigens in human colorectal cancer
Laurence M. Sandler (1929-1987) PhD heart attack University of Washington School of Medicine cytogenetics of meiosis and development in drosophila
DeWitt S. Goodman (1930-1991) MD pulmonary embolism Columbia University lipid metabolism and its role in the development of heart and artery disease
George B. Craig, Jr. (1930-1995) PhD heart attack University of Notre Dame genetics and reproductive biology of aedes mosquitoes
Hymie L. Nossel (1930-1983) MD/PhD heart attack Columbia University causes of thrombosis and the nature of hemostasis
James W. Prahl (1931-1979) MD/PhD rock climing accident University of Utah structural basis of the functions of human complement
Harold A. Baltaxe (1931-1985) MD heart attack University of California — Davis development of new coronary angiographic techniques
George J. Schroepfer, Jr. (1932-1998) MD/PhD heart attack Rice University regulation of the formation and metabolism of cholesterol
Philip J. Fialkow (1933-1996) MD trekking accident in Nepal University of Washington origins of myeloid leukemia tumors
John C. Seidel (1933-1988) PhD heart attack Boston Biomedical Research Institute actin-myosin interaction in pulmonary smooth muscle
Issa Yaghmai (1933-1992) MD sudden cardiac arrest UCLA-Olive View Medical Center radiological diagnosis of musculoskeletal disorders
Donald C. Shreffler (1933-1994) PhD heart attack Washington University in St. Louis organization and functions of H-2 gene complex
Paul B. Sigler (1934-2000) MD/PhD heart attack Yale University structural analysis of biological macromolecules
Kenneth L. Melmon (1934-2002) MD heart attack Stanford University autacoids as pharmacologic modifiers of immunity
Gerald P. Murphy (1934-2000) MD heart attack Roswell Park Cancer Institute/SUNY Buffalo detection, immunotherapy, and prognostic indicators of prostate cancer
Demetrios Papahadjopoulos (1934-1998) PhD adverse drug reaction/multi-organ failure UCSF phospholipid-protein interactions, lipid vesicles, and membrane function
Takis S. Papas (1935-1999) PhD unexpected and sudden Medical University of South Carolina characterization of ETS genes and retroviral onc genes
Donald T. Witiak (1935-1998) PhD stroke University of Wisconsin stereochemical studies of hypocholesterolemic agents
Shu-Ren Lin (1936-1979) MD plane crash University of Rochester imaging studies of cerebral blood flow after cardiac arrest
James R. Neely (1936-1988) PhD heart attack Penn State University effects of diabetes and oxygen deficiency in regulation of metabolism in the heart
D. Martin Carter (1936-1993) MD/PhD dissecting aortic aneurysm Rockefeller University susceptibility of pigment and cutaneous cells to DNA injury by UV
Dale E. McFarlin (1936-1992) MD heart attack NIH neuroimmunological studies of multiple sclerosis
Roy D. Schmickel (1936-1990) MD died tragically University of Pennsylvania isolation and characterization of human ribosomal DNA
John J. Jeffrey, Jr. (1937-2001) PhD stroke Albany Medical College mechanism of action and the physiologic regulation of mammalian collagenases
Victor J. Ferrans (1937-2001) MD/PhD complications from diabetes NIH myocardial and vascular pathobiology
Sandy C. Marks, Jr. (1937-2002) DDS/PhD heart attack UMASS bone cell biology
A. Arthur Gottlieb (1937-1998) MD pulmonary embolus following surgery Tulane University School of Medicine role of macrophage nucleic acid in antibody production
Patricia S. Goldman-Rakic (1937-2003) PhD struck by a car Yale University development and plasticity of the primate frontal lobe
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ixThomas P. Dousa (1937-2000) MD/PhD heart attack Mayo Clinic cellular action of vasopressin in the kidney
William L. McGuire (1937-1992) MD scuba-diving accident University of Texas HSC at San Antonio mechanisms of hormonal control and growth and regression of mammary carcinoma
Roland L. Phillips (1937-1987) MD/PhD glider plane accident Loma Linda University School of Medicine role of lifestyle in cancer and cardiovascular disease among Adventists
Emil T. Kaiser (1938-1988) PhD complications from kidney transplant Rockefeller University mechanism of carboxypeptidase action
John H. Walsh (1938-2000) MD heart attack UCLA gastrointestinal hormones, gastric acid production and peptic ulcer disease
Harold A. Menkes (1938-1987) MD car accident Johns Hopkins University occupational and environmental lung disease
Thomas F. Burks, II (1938-2001) PhD heart attack University of Texas HSC at Houston central and peripheral neuropeptide pharmacology
Verne M. Chapman (1938-1995) PhD died suddenly while attending meeting Roswell Park Cancer Institute/SUNY Buffalo development of cumulative multilocus map of mouse chromosomes
Samuel A. Latt (1938-1988) MD/PhD heart attack Harvard Medical School/Children’s Hospital genetic and cytogenetic studies of mental retardation
Walter F. Heiligenberg (1938-1994) PhD plane crash UCSD neuroethological studies of electrolocation
Dolph O. Adams (1939-1996) MD/PhD heart attack Duke University Development and regulation of macrophage activation
James N. Davis (1939-2003) MD airplane crash SUNY HSC at Stony Brook mechanisms underlying neuronal injury after brain ischemia
Raymond R. Margherio (1940-2000) MD aneurysm Wayne State University School of Medicine clinical studies in age-related eye diseases
Robert M. Macnab (1940-2003) PhD accidental fall Yale University sequence analysis and function of bacterial flagellar motor
D. Michael Gill (1940-1990) PhD heart attack Tufts University biochemistry of cholera toxin and other pathogenic toxins
Anthony Dipple (1940-1999) PhD heart attack NIH metabolic activation and DNA interactions of polycyclic aromatic hydrocarbon carcinogens
Ronald G. Thurman (1941-2001) PhD massive heart attack University of North Carolina hepatic metabolism, alcoholic liver injury and toxicology
Richard E. Heikkila (1942-1991) PhD murder UMDNJ Robert Wood Johnson Medical School oxidation-reduction reactions and the dopamine receptor system
Julio V. Santiago (1942-1997) MD heart attack Washington University in St. Louis role of social factors, lifestyle practices, and medication in the onset of type II diabetes
Pokar M. Kabra (1942-1990) PhD plane crash UCSF application of liquid chromatography to therapeutic drug monitoring
Simon J. Pilkis (1942-1995) MD/PhD heart attack University of Minnesota carbohydrate metabolism and diabetes
Christopher A. Dawson (1942-2003) PhD heart attack Medical College of Wisconsin pulmonary hemodynamics
Bruce M. Achauer (1943-2002) MD gastrointestinal bacterial infection University of California — Irvine non-invasive methods to assess the depth of burn wounds
Roland D. Ciaranello (1943-1994) MD heart attack Stanford University molecular neurobiology and developmental disorders
Fredric S. Fay (1943-1997) PhD heart attack UMASS generation and regulation of force in smooth muscle
Thomas A. McMahon (1943-1999) PhD complications from routine surgery Harvard University orthopedic biomechanics
William D. Nunn (1943-1986) PhD sudden cardiac arrest University of California — Irvine regulation of fatty acid/acetate metabolism in e. coli
Ahmad I. Bukhari (1943-1983) PhD heart attack Cold Spring Harbor Laboratory life cycle of mutator phage μ
James S. Seidel (1943-2003) MD/PhD bacterial infection Harbor-UCLA Medical Center clinical studies in pediatric  life support and cardiopulmonary resuscitation
Jonathan M. Mann (1943-1998) MD plane crash Harvard University School of Public Health AIDS prevention
Lonnie D. Russell, Jr. (1944-2001) PhD swimming accident Southern Illinois University School of Medicine filament regulation of spermatogenesis
Don C. Wiley (1944-2001) PhD accidental fall Harvard University viral membrane and glycoprotein structure
Roger R. Williams (1944-1998) MD airplane crash University of Utah genetics and epidemiology of coronary artery diseases
G. Scott Giebink (1944-2003) MD heart attack University of Minnesota pathogenesis of otitis media and immunizations
Joaquim Puig-Antich (1944-1989) MD asthma attack University of Pittsburgh psychobiology and treatment of child depression
Peter M. Steinert (1945-2003) PhD heart attack NIH structures and interactions of the proteins characteristic of epithelial cells
John P. Merlie (1945-1995) PhD heart failure Washington University in St. Louis molecular genetics of the acetylcholine receptor
Howard S. Tager (1945-1994) PhD heart attack University of Chicago biochemical structure, action, regulation and degradation of the insulin and glucagon molecules
John J. Wasmuth (1946-1995) PhD heart attack University of California — Irvine human-hamster somatic cell hybrids/localization of Hnyington’s disease gene
Stanley R. Kay (1946-1990) PhD heart attack Albert Einstein College of Medicine symptoms and diagnostic tests of schizophrenia
Mary Lou Clements (1946-1998) MD airplane crash Johns Hopkins University development of AIDS vaccines
Ronald E. Talcott (1947-1984) PhD automobile accident UCSF carboxylesterases of toxicologic significance
Lynn M. Wiley (1947-1999) PhD plane crash University of California — Davis morphogenesis in early mammalian embryos
John B. Penney, Jr. (1947-1999) MD heart attack Harvard Medical School/MGH receptor mechanisms in movement disorder pathophysiology
Jeffrey M. Isner (1947-2001) MD heart attack Tufts University therapeutic angiogenesis in vascular medicine, cardiovascular laser phototherapy
Trudy L. Bush (1949-2001) PhD heart attack University of Maryland School of Medicine postmenopausal estrogen/progestins interventions
Neil S. Jacobson (1949-1999) PhD heart attack University of Washington marital therapy, domestic violence, and the treatment of depression
Tsunao Saitoh (1949-1996) PhD murdered UCSD altered protein kinases in alzheimer’s disease
Gary J. Miller (1950-2001) MD/PhD heart attack University of Colorado HSC vitamin D receptors in the growth regulation of prostate cancer cells
Elizabeth A. Rich (1952-1998) MD traffic accident Case Western Reserve University School of Medicine natural history of lymphocytic alveolitis in hiv disease
Matthew L. Thomas (1953-1999) PhD died while travelling Washington University in St. Louis function and regulation of leukocyte surface glycoproteins
Mu-En Lee (1954-2000) MD/PhD complications from routine surgery Harvard Medical School/MGH characterization of vascular smooth muscle LIM protein
Alan P. Wolffe (1959-2001) PhD car accident NIH role of DNA methylation in regulating gene expression in normal and pathological states
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Guillemin  Dyad 
Top 10 overlapping MeSH terms 
with highest combined use  
Animals 170 49 
Rats 127 33 
Male 131 23 
Gonadotropin-Releasing Hormone  121 9 
Luteinizing Hormone  121 8 
Humans 94 23 
Female 106 8 
Follicle Stimulating Hormone  81 6 
Pituitary Gland  65 19 
Time Factors  54 8 
Top 10 overlapping MeSH terms 
with lowest combined use  
Molecular Weight  1 1 
Somatomedins 1 1 
Peptide Chain Termination, Translational 1 1 
Steroids 1 1 
Arginine Vasopressin  1 1 
Propylthiouracil 1 1 
Neural Pathways  1 1 
Electric Stimulation 1 1 
Cerebellum 1 1 
Fatty Acids, Nonesterified  1 1 
Number of Publications  240 60 
Number of MeSH Terms (freq.-unweighted) 534 220 
Number of MeSH Terms (freq.-weighted) 3,035 750 
Number of Ovrlp. MeSH Terms (freq.-unweighted) 147
Number of Ovrlp. MeSH Terms (freq.-weighted) 609
Proximity of Guillemin to Schally (freq.-unweighted) 0.668
Proximity of Schally to Guillemin (freq.-unweighted) 0.275
Proximity of Guillemin to Schally (freq.-weighted) 0.812
Proximity of Schally to Guillemin (freq.-weighted) 0.201
 xii 
Table W3 
Trends in Stars’ Publication Output Around the Time of Death 








































Log Quasi-Likelihood  -831,596  -626,787 
Nb. of Obs.  104,154  103,959 
Notes: The estimates above are taken from a conditional fixed effects Poisson specification that also include 54 career 
age indicator variables and a full suite of calendar year effects (estimates not reported). The estimate in column (1) 
implies a statistically significant (1-exp[-.988]))=62.77% decrease in the rate of publication two years after a superstar 
scientist passes away (regardless of cause of death), relative to years prior to the last 5 years of his/her life. The 
dependent variable in column 1 is the weighted article count for the superstar. Columns 2 restricts the count to 
publications in which the superstar appears in last position on the authorship roster. The weights used to create these 
counts are Journal Impact Factors (JIF) published by the Institute for Scientific Information. Robust (QML) 
standard errors are reported in parentheses. 
†p < 0.10, 
*p < 0.05, 
**p < 0.01 
 
Table W4 
Impact of Superstar Death on Collaborators’ Publication Rates – OLS 
  All JIF-Weighted 
Publications 
JIF-Weighted Pubs. 
Written with others 








  (1a) (1b) (2a)  (2b) 













2 0.574  0.566  0.576  0.569 
Nb. of Obs.  153,508  294,943  153,508  294,943 
Nb. of Collaborators  5,267  10,128  5,267  10,128 
 
Notes: Estimates stem from collaborator fixed effects linear specifications. Dependent variable is the total number of 
JIF-weighted articles authored by a collaborator of a superstar life scientist in the year of observation. All models 
incorporate a full suite of year effects as well as 54 age category indicator variables (career age less than -3 is the 
omitted category). Robust standard errors in parentheses, clustered at the level of the superstar. 
†p < 0.10, 
*p < 0.05, 
**p < 0.01 xiii 
Table W5 
Impact of Superstar Death on Collaborators’ Citation Impact [Elite Subsample] 
 
JIF-wghtd. 



















  (1) (2) (3) (4) (5) (6) (7) (8) 























Log  Pseudo-Likl.  -773,535 -226,069  -46,236  -98,925  -207,452 -185,282 -125,897  -69,291 
Nb.  of  Obs.  86,457 86,457 86,457 86,457 86,457 86,457 86,457 86,457 
Nb.  of  Collabs.  2,852 2,852 2,852 2,852 2,852 2,852 2,852 2,852 
Notes: Conditional fixed effects quasi-maximum likelihood estimates for the determinants of publication rates among coauthors of “superstar” academic life scientists. 
We bin their publications according to the various quantiles of the vintage-specific, article-level distribution of citations they fall into. For instance, an article that 
garnered 100 citations by 2008 would fall above the top ventile of the 1980 citation distribution, but above the top percentile of the 2000 distribution. The underlying 
empirical distributions were computed using the universe of publications and citations in the biomedical and chemical journals indexed by ISI/Web of Science (Table 
W2). Because article-level citation data is only available for scientists in the elite subsample (n=10,349), we restrict the estimation sample to elite coauthors, which 
account for a 28.16% of the collaborators in the overall sample. All models incorporate year effects and 17 age category indicator variables (career age less than -3 is 
the omitted category). Robust (QML) standard errors in parentheses, clustered at the level of the superstar. 
†p < 0.10, 
*p < 0.05, 




Impact of Superstar Death on Receipt of NIH Funding 
  Nb. of Grants  At Least One Grant 








  (1a) (1b) (2a)  (2b) 













2 -44,166  -83,644 0.230 0.221 
Nb. of Obs.  92,014  175,062  143,727  277,922 
Nb. of Collaborators  3,140  5,965  4,949  9,574 
 
Notes: Estimates stem from collaborator fixed effects QML Poisson specifications (columns (1a) and (1b)) and 
collaborator fixed effects linear probability model specifications (columns (2a) and (2b)). Estimates stem from 
conditional quasi-maximum likelihood Poisson specifications. The dependent variable in columns 1a and 1b is the 
total number of NIH research grants and contracts (R, U, N, or K codes, new grants or competitive renewals) 
awarded in the year of observation. In columns (2a) and (2b), the dependent variable is an indicator for award of at 
least one such grant or contract. All models incorporate a full suite of year effects as well as 17 age category indicator 
variables (career age less than -3 is the omitted category). Robust standard errors in parentheses, clustered at the 
level of the superstar. 
 
†p < 0.10, 
*p < 0.05, 
**p < 0.01 xv 
Table W7 
Impact of Collaborator Status at the Time of Superstar Death 








 (1)  (2)  (3)  (4) 












After Death × 




























% of Collabs. Affected  27.66  56.50  8.48   
Log Pseudo-Likelihood  -1,832,458  -1,832,586  -1,832,104  -1,832,022 
Nb. of Obs.  294,943  294,943  294,943  294,943 
Nb. of Collabs.  10,128  10,128  10,128  10,128 
Notes: Estimates stem from conditional quasi-maximum likelihood Poisson specifications. Dependent variable is the total number of JIF-weighted articles 
authored by a collaborator of a superstar life scientist in the year of observation. We interact the treatment variable with indicator variables capturing 
various aspects of coauthor status: poor substitution opportunities, i.e., coauthors with no other elite coauthor save the extinct superstar; R01 grantee 
status at the time of death; and a composite “Elite” indicator variable combining membership in the National Academy of Science, MERIT Award from 
the NIH, and HHMI investigatorship. All models incorporate year effects and 17 age category indicator variables (career age less than -3 is the omitted 
category), as well as 17 interaction terms between the age effects and the covariate of interest. Robust (QML) standard errors in parentheses, clustered 
at the level of the superstar. 
†p < 0.10, 
*p < 0.05, 



















 (1)  (2)  (3)  (4a)  (4b)  (5)  (6) 



















Robustness  Table III, 
Column (1b) 






<60 yrs old  >75 yrs old  path length>2  Only 
Controls 
Log Likelihood  -1,832,594  -1,517,842  -1,827,615  -1,048,026  -627,820  -1,338,509  -914,468 
Nb. of Obs.  294,943  246,405  294,943  165,635  106,696  218,400  147,339 
Nb.  of  Collabs.  10,128  8,488  10,128  5,694  3,594 7,510 5,064 
Notes: Estimates stem from conditional quasi-maximum likelihood Poisson specifications. Dependent variable is the total number of JIF-weighted articles authored 
by a collaborator of a superstar life scientist in the year of observation. All models incorporate year effects and 17 age category indicator variables (career age less 
than -3 is the omitted category). Robust (QML) standard errors in parentheses, clustered at the level of the superstar. 
 
†p < 0.10, 
*p < 0.05, 




Impact of Superstar Death on Collaborators’ Publication Rates 
(136 stars whose premature deaths could be anticipated) 
  All JIF-Weighted 
Publications 
JIF-Weighted Pubs. 
Written with others 








  (1a) (1b) (2a)  (2b) 










Log Pseudo-Likelihood  -1,186,953  -2,213,193  -1,159,119  -2,152,735 
Nb. of Obs.  191,771  370,166  191,771  370,166 
Nb. of Collaborators  6,515  12,592  6,515  12,592 
 
Notes: Estimates stem from conditional quasi-maximum likelihood Poisson specifications. Exponentiating the coefficients and differencing from one yield numbers 
interpretable as elasticities. For example. the estimates in column (1a) imply that collaborators suffer on average a statistically significant (1-exp[-0.092])=8.79% 
decrease in the rate of publication after their superstar coauthor passes away. All models incorporate a full suite of year effects as well as 17 age category indicator 
variables (career age less than -3 is the omitted category). Robust (QML) standard errors in parentheses, clustered at the level of the superstar. 
†p < 0.10, 
*p < 0.05, 











Coauthor Matching for a Sample Publication 
R. Eugene Langevin, MD. Radiology.
Tufts School of Medicine.
2 coauthorships.
Bernard D. Kossowsky, MD.
Medicine. Tufts School of 
Medicine.
6 coauthorships.
Ambiguous: 3 possible matches
in the roster
Unmatched
John O. Pastore, MD. Medicine.
Tufts School of Medicine.
7 coauthorships.
Syed Razvi, MD. Surgery. Tufts 
School of Medicine.
1 coauthorship.
Douglas W. Losordo, MD.
Medicine.







Vintage-specific Empirical Distributions of Citations 
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Magnitude of the Treatment Effect as a Function of 






5 10 15 20 25 30 35 40
 
Collaborator Age at Death
 
Notes: The solid blue lines in the above plot correspond to coefficient estimates of a conditional fixed effects 
quasi-maximum likelihood Poisson specification in which the weighted publication output of a collaborator is 
regressed onto year effects, 17 indicator variables corresponding to different age brackets, and interactions of the 
treatment effect with 8 indicator variables corresponding to different brackets for the career age of the 
collaborator at the time of superstar death: 5 to 10 years, 10 to 15 years, 15 to 20 years, 20 to 25 years, 25 to 30 
years, 30 to 35 years, 35 to 40 years, and more than 40 years of career age. The 95% confidence interval 
(corresponding to robust standard errors, clustered around superstars) around these estimates is plotted with 
dashed red lines. The baseline specification is that of Table III, Column (1b). xx 
Figure W4 
Dynamics of the Treatment Effect 










The solid blue lines in the above plot correspond to coefficient estimates of a conditional fixed effects quasi-
maximum likelihood Poisson specification in which the weighted publication output of a collaborator is regressed 
onto year effects, 17 indicator variables corresponding to different age brackets, and interactions of the 
treatment effect with 27 indicator variables corresponding to 11 years before the year of death and prior, 10 
years before the year of death, 9 years before the year of death,…, 14 years after the year of death, and 15 
years after the year of death and above (the indicator variable for treatment status interacted with the year of 
death is omitted). The 95% confidence interval (corresponding to robust standard errors, clustered around 
superstars) around these estimates is plotted with dashed red lines. The figure uses Column (1b) of Table W9 as 
a baseline (i.e., treated and control collaborators, the dep. var. includes all of the collaborator’s publications) 
 